Matthew H.G. Katz, MD, CMQ, FACS, FASCO, FSSO

Peer-Reviewed Articles

1. Stoop, TF, Lutchman, KR, Theijse, R, Larsson, P, Oba, A, Koerkamp, BG, van Eijck, CH, Wolfgang, CL, Rangelova, E, Marchegiani, G, Endo, I, Jang, JY, Primrose, JM, Ramia, JM, Katz, MH, Abu Hilal, M, Ghorbani, P, Shrikhande, SV, Hackert, T, Nealon, WH, Truty, MA, Del Chiaro, M, Besselink, MG, Rompen, IF, Zyromski, NJ, Madhavan, KK, De Wilde, RF, Mieog, JD, Schulick, RD, Satoi, S. Staging laparoscopy to detect occult metastases in localized pancreatic cancer. HPB 28(3):313-323, 2026. e-Pub 2026. PMID: 41421934.
2. Wright, RD, Lu, P, Prakash, L, Chiang, YJ, Tzeng, CD, Maxwell, JE, Ikoma, N, Kim, M, Lee, JE, Katz, MH, Snyder, RA. ASO Visual Abstract: Incidence of Venous Thromboembolism in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Chemotherapy. Annals of surgical oncology 33(3):2703, 2026. e-Pub 2026. PMID: 41507449.
3. Marincola Smith, P, Tomita, K, Cass, SH, Hirata, Y, Pan, C, Shen, SE, Wang, X, Wang, XS, Williams, LA, Arvide, M, To, C, Rajaram, R, Rice, DC, Hofstetter, WL, Antonoff, MB, Mehran, RJ, Vaporciyan, AA, Walsh, GL, Maxwell, JE, Snyder, RA, Kim, M, Tzeng, CD, Badgwell, BD, Mansfield, PF, Katz, MH, Swisher, SG, Lee, JE, Ikoma, N. Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers. Annals of surgical oncology 33(2):1332-1342, 2026. e-Pub 2026. PMID: 41057745.
4. Tustumi, F, Calthorpe, L, Fotoohi, N, Ribeiro, TC, Stolzemburg, LP, Bettiati Junior, AL, Gonçalves, CA, de Almeida, AB, Giordano, AM, Godoy, AL, Altenfelder, D, Nicioli, J, Guimarães, AC, Requejo, AS, Diniz, AL, Oliveira, AF, Wei, AC, de Moricz, A, Montagnini, A, Visser, BC, Chan, CH, de Oliveira, CV, Ferrone, CR, Asbun, D, Jonas, E, Ramos, EJ, Nickel, F, Maia, FO, Apodaca-Torrez, FR, Barreto, SG, Hewitt, DB, de Farias, IC, Frigerio, I, Jang, JY, Anghinoni, M, Boff, MF, Belotto, M, Giménez, ME, Nakamura, M, Katz, MH, Hogg, M, Kendrick, M, Luyer, MD, Abu Hilal, M, Ikoma, N, Zyromski, NJ, Járufe, N, Guevara, OA, Mazza, O, Polanco, PM, Amaral, Pd, Pinheiro, RN, Jeyarajah, DR, Gaujoux, S, Shrikhande, SV, Torres, SM, Siriwardena, AK, Kent, TS, Hackert, T, Pawlik, TM, Andraus, W, Boggi, U, Asbun, HJ, Alseidi, A, Coimbra, FJ. The São Paulo International Consensus on Minimally Invasive Pancreatic Surgery for Cancer. HPB 28(2):105-118, 2026. e-Pub 2026. PMID: 41419350.
5. Imamura, T, Maxwell, JE, Snyder, RA, Kim, M, Cao, HS, Tzeng, CD, Katz, MH, Ikoma, N. Stapled Wedge Resection of the Portal Vein/Superior Mesenteric Vein During Robotic Pancreaticoduodenectomy. Annals of surgical oncology 33(2):1638-1639, 2026. e-Pub 2026. PMID: 41247601.
6. Stoop, TF, Seelen, LW, van ’t Land, FR, van der Hout, AC, Scheepens, JC, Ali, M, Stiggelbout, AM, van der Kolk, BM, Bonsing, BA, Lips, DJ, de Groot, DJ, van Veldhuisen, E, Kerver, ED, Manusama, ER, Daams, F, Kazemier, G, Cirkel, GA, Van Tienhoven, G, Patijn, GA, Lelieveld-Rier, HN, de Hingh, IH, van Hellemond, IE, Wijsman, JH, Erdmann, J, Mieog, S, de Vos-Geelen, J, De Groot, JB, Lutchman, KR, Mekenkamp, LJ, Kranenburg, LW, Beuk, LP, Nijkamp, MW, den Dulk, M, Polee, M, Homs, MY, Wumkes, ML, Stommel, MW, Busch, O, De Wilde, RF, Theijse, R, Luelmo, SA, Festen, S, Bollen, TL, Neumann, U, de Meijer, VE, Draaisma, WA, Koerkamp, BG, Molenaar, IQ, Wolfgang, CL, Katz, MH. Nationwide implementation of the international multidisciplinary best-practice for locally advanced pancreatic cancer (PREOPANC-4). BMC cancer 25(1), 2025. e-Pub 2025. PMID: 39972248.
7. Takayama M, Snyder RA, Lyu HG, Mensah CK, Prakash LR, Landry JP, Tsai E, Siddiqui ZA, Maxwell JE, Kim MP, Tzeng CD, Lee JE, Katz MHG, Ikoma N. ASO Visual Abstract: Association Between Intraoperative Hypothermia and Postoperative Pancreatic Fistula. Ann Surg Oncol 32(13):10056, 2025. e-Pub 2025. PMID: 41085798.
8. Imamura T, Maxwell JE, Snyder RA, Kim MP, Tran Cao HS, Tzeng CD, Katz MHG, Ikoma N. Multimedia Articles/Streaming Video Articles: Selective Dissection of the Superior Mesenteric Artery Nerve Plexus in Robotic Pancreatoduodenectomy-Technical and Case-Based Insights. Ann Surg Oncol 32(13):10039-10040, 2025. e-Pub 2025. PMID: 40962959.
9. Takayama M, Snyder RA, Lyu HG, Mensah CK, Prakash LR, Landry JP, Tsai E, Siddiqui ZA, Maxwell JE, Kim MP, Tzeng CD, Lee JE, Katz MHG, Ikoma N. Association Between Intraoperative Hypothermia and Postoperative Pancreatic Fistula. Ann Surg Oncol 32(13):9979-9987, 2025. e-Pub 2025. PMID: 40935892.
10. Lewis, KA, Lyu, H, Yammanur, M, Larsson, L, Willis, JA, Smaglo, BG, Katz, MH, Snyder, RA. Real-time implementation and validation of a natural language processing tool to improve clinical trial enrollment in pancreatic cancer. JCO Oncology Practice 21:127, 2025. e-Pub 2025.
11. Wright RD, Lu P, Prakash L, Chiang YJ, Tzeng CD, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Snyder RA. Incidence of Venous Thromboembolism in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 41207950.
12. Tomita K, Takeuchi M, Takayama M, Kim MP, Maxwell JE, Snyder RA, Tran Cao HS, Tzeng CD, Lee JE, Katz MHG, Ikoma N. Development of a novel artificial intelligence model to recognize vascular anatomy during robotic pancreatoduodenectomy. Br J Surg 112(11), 2025. e-Pub 2025. PMID: 41236618.
13. Wang L, Li R, Wen A, Lu Q, Wang J, Ruan X, Gamboa A, Malik N, Roland CL, Katz MHG, Lyu H, Liu H. Discovering signature disease trajectories in pancreatic cancer and soft-tissue sarcoma from longitudinal patient records. J Biomed Inform 171:104935, 2025. e-Pub 2025. PMID: 41120049.
14. Elzamly S, Alsawas M, Yousef MMG, Zhao D, Katz MH, Prakash LR, Wang H, Li Z, Wolff RA, Maitra A, Wang H. Clinicopathologic Characteristics of Brain Metastasis of Pancreatic Ductal Adenocarcinoma. Am J Surg Pathol 50(1):74-83, 2025. e-Pub 2025. PMID: 40936196.
15. Katz MHG, Francescatti AB, Mullett TW, Harris J, Bleznak AD, Nelson H, Weigel RJ, Reuter EK, Pastore BM, Funk EC, Chan K, Carpenter PJ, Burns WR, Teshome M, Vreeland TJ, Hunt KK, Hieken TJ. First National Effort to Optimize the Performance of Cancer Surgery by the American College of Surgeons Commission on Cancer and Cancer Surgery Standards Program: Early Results After Implementation of the Operative Standards. Ann Surg 282(3):371-381, 2025. e-Pub 2025. PMID: 40495788.
16. Hierl, AN, Hirata, Y, Maxwell, JE, Tzeng, CD, Austin, M, Perrier, ND, Lee, JE, Katz, MH, Ikoma, N. Robotic Spleen-Preserving Distal Pancreatectomy for Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1. Annals of surgical oncology 32(9):6559-6560, 2025. e-Pub 2025. PMID: 40531401.
17. Lyu HG, Hirata Y, Lu PW, Maxwell JE, Snyder RA, Kim MP, Tran Cao H, Tzeng CD, Katz MHG, Ikoma N. Analysis of hospital costs for robotic and open pancreatectomy incurred during the implementation of a robotic pancreatectomy program at a cancer center. Ann Gastroenterol Surg 9(5):1066-1074, 2025. e-Pub 2025. PMID: 40922924.
18. Herb J, Liao KP, Lin JK, Lewis KA, Giordano SH, Katz MHG, Snyder RA. Racial and Ethnic Disparities in Receipt of Guideline-Concordant Pancreatic Cancer Care Among Older Adults in the United States. JCO Oncol Pract:OP2500351, 2025. e-Pub 2025. PMID: 40768681.
19. Tomita K, Takeuchi M, Maxwell JE, Snyder RA, Kim MP, Tran Cao HS, Tzeng CD, Lee JE, Katz MHG, Ikoma N. Automated surgical phase recognition for robotic pancreatoduodenectomy using artificial intelligence. Br J Surg 112(7), 2025. e-Pub 2025. PMID: 40728177.
20. Hirata Y, Prakash L, Maxwell J, Snyder R, Kim M, Tran Cao H, Tzeng CD, Lee JE, Katz MHG, Ikoma N. Institutional learning curve and factors of prolonged operation time of robotic distal pancreatectomy: An analysis of an initial 117 cases. Ann Gastroenterol Surg 9(4):861-869, 2025. e-Pub 2025. PMID: 40607303.
21. Katsumata K, Kim MP, Maxwell JE, Snyder RA, Cao HST, Tzeng CD, Katz MHG, Ikoma N. Robotic Approach to Oncologic Pancreatoduodenectomy in a Case with an Aberrant Hepatic Artery Originating from the Superior Mesenteric Artery. Ann Surg Oncol 32(10):7241-7242, 2025. e-Pub 2025. PMID: 40563028.
22. Bernard V, Ku LT, Wang T, Acevedo-Diaz A, Rajapakshe KI, Jacobson G, Tovar D, Min J, Pei G, Tat C, Suresh A, Tzeng CD, Katz MH, Bhutani MS, Wang H, Wolff RA, Haymaker C, Ludmir EB, Huang H, Chen X, Li L, Koong AC, Wang L, Navin NE, Jiang D, Li Z, Maitra A, Koay EJ. A spatial atlas of chemoradiation therapy in pancreatic cancer identifies cellular and microenvironmental determinants of persister populations. bioRxiv, 2025. e-Pub 2025. PMID: 40667350.
23. Fields BC, Newhook TE, Lillemoe HA, Maxwell JE, Soliz JM, Popat KU, Roland CL, Vauthey JN, Katz MHG, Tzeng CD. Persistent Improvement in Opioid Perceptions and Prescribing for Cancer Surgery: 5-Year Follow-Up. Adv Cancer Educ Qual Improv 1(1), 2025. e-Pub 2025. PMID: 40453772.
24. Fields BC, Soliz JM, Speer BB, Hancher-Hodges S, Popat KU, Ghebremichael SJ, Van Meter A, Williams UU, Wang X, Hwang H, Bruno ML, Dewhurst WL, Arvide EM, Ikoma N, Maxwell JE, Kim MP, Katz MHG, Tzeng CD, Newhook TE. Repeat versus Single Quadratus Lumborum Block to Reduce Opioids After Open Pancreatectomy (RESQU-BLOCK): A Randomized Clinical Trial. Ann Surg, 2025. e-Pub 2025. PMID: 40421798.
25. Baskin AS, Funk EC, Francescatti AB, Sinco BR, Palis BE, Hieken TJ, Katz MHG, Boughey JC, Weigel RJ, Dossett LA, Boffa DJ. Early compliance with lung cancer lymph node standard 5.8: An analysis of 2022 and 2023 Commission on Cancer site reviews. J Thorac Cardiovasc Surg 170(4):926-932, 2025. e-Pub 2025. PMID: 40324749.
26. Fields, BC, Newhook, TE, Prakash, L, Arvide, EM, Li, Z, Tran Cao, HS, Maxwell, JE, Perrier, ND, Katz, MH, Vauthey, JN, Tzeng, CD. Impact of Nonhepatectomy Opioid Reduction Efforts on Posthepatectomy Opioid Prescription. Journal of the American College of Surgeons 240(4):474-487, 2025. e-Pub 2025. PMID: 39807798.
27. Ishida H, Stoop TF, Oba A, Bachellier P, Ban D, Endo I, Franklin O, Fujii T, Gulla A, Hackert T, Halimi A, Hirano S, Jang JY, Katz MHG, Maekawa A, Nealon WH, Perri G, Ramia JM, Rompen IF, Satoi S, Schulick RD, Shrikhande SV, Tsung A, Wolfgang CL, Besselink MG, Del Chiaro M. Global survey on surgeon preference and current practice for pancreatic neck and body cancer with portomesenteric venous involvement. HPB (Oxford), 2025. e-Pub 2025. PMID: 40204592.
28. Tomita K, Maxwell JE, Snyder RA, Kim MP, Tran Cao HS, Tzeng CD, Katz MHG, Ikoma N. Robotic Central Pancreatectomy: Patient Selection and Surgical Approach. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 40045147.
29. Wang L, Li R, Wen A, Lu Q, Wang J, Ruan X, Gamboa A, Malik N, Roland CL, Katz MHG, Lyu H, Liu H. Discovering Signature Disease Trajectories in Pancreatic Cancer and Soft-tissue Sarcoma from Longitudinal Patient Records. medRxiv, 2025. e-Pub 2025. PMID: 40034771.
30. Dekker EN, van Klaveren D, Verkolf EMM, de Wilde RF, Besselink MG, O'Reilly EM, Paniccia A, Katz MHG, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B. Carbohydrate antigen 19-9 (CA19-9) response after induction FOLFIRINOX for locally advanced pancreatic cancer identifies patients who may benefit from surgical exploration: multicentre, observational cohort study. Br J Surg 112(2), 2025. e-Pub 2025. PMID: 39967445.
31. Cloyd JM, Sarna A, Arango MJ, Bates SE, Bhutani MS, Bloomston M, Chung V, Dotan E, Ferrone CR, Gambino PF, Goenka AH, Goodman KA, Hall WA, He J, Hogg ME, Jayaraman S, Kambadakone A, Katz MHG, Khorana AA, Ko AH, Koay EJ, Kooby DA, Krishna SG, Larsson LK, Lee RT, Maitra A, Massarweh NN, Mikhail S, Muzaffar M, O'Reilly EM, Palta M, Petzel MQB, Philip PA, Reyngold M, Santa Mina D, Sohal DPS, Sundaresan TK, Tsai S, Turner KL, Vreeland TJ, Walston S, Washington MK, Williams TM, Wo JY, Snyder RA. Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. JAMA Surg 160(2):172-180, 2025. e-Pub 2025. PMID: 39630427.
32. Yousef M, Hurd MW, Yousef A, Ludmir EB, Pillai AB, Peterson J, Koay EJ, Albarouki S, Tzeng CW, Snyder R, Katz MHG, Wang H, Overman MJ, Maitra A, Pant S, Smaglo BG, Wolff RA, Yao J, Shen JP, Zhao D. Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma. Oncologist 30(1), 2025. e-Pub 2025. PMID: 39014543.
33. Horowitz, M, Sample, J, Rudasill, S, Zaveri, S, Francescatti, A, Teshome, M, Villano, AM, Hieken, TJ, Katz, MH, Hunt, KK. Setting the Standard for the Future of Cancer Surgery. Journal of Surgical Education 82(1), 2025. e-Pub 2025. PMID: 39581164.
34. Ibrahim RM, Solanki S, Qiao W, Hwang H, Singh BS, Cazacu IM, Saftoiu A, Katz MHG, Kim MP, McAllister F, Bhutani MS. Fatty pancreas on EUS: Risk factors, correlation with CT/MRI, and implications for pancreatic cancer screening. Endosc Ultrasound 14(1):13-19, 2025. e-Pub 2025. PMID: 40151596.
35. Habib, JR, Kinny-Köster, B, Javed, A, Zelga, P, Saadat, L, Kim, RC, Gorris, M, Allegrini, V, Watanabe, S, Sharib, J, Arcerito, M, Kaiser, J, Lafaro, KJ, Tu, M, Bhandre, M, Shi, C, Kim, M, Correa, C, Daamen, LA, Oberstein, PE, Schmidt, CM, Hanna, N, Allen, PJ, Loos, M, Shrikhande, SV, Molenaar, IQ, Frigerio, I, Katz, MH, Soares, KC, Miao, Y, Del Chiaro, M, He, J, Hackert, T, Salvia, R, Büchler, M, Castillo, Cd, Besselink, MG, Marchegiani, G, Wolfgang, CL, Prakash, L, Grewal, M, Pea, A, Butturini, G, Hecker, M, Van Oosten, F. Impact of Adjuvant Chemotherapy on Resected Intraductal Papillary Mucinous Neoplasm-Derived Pancreatic Cancer. Journal of Clinical Oncology 42(36):4317-4326, 2024. e-Pub 2024. PMID: 39255450.
36. Torres, MB, Maxwell, JE, Snyder, RA, Cao, HS, Kim, M, Tzeng, CD, Lee, JE, Katz, MH, Ikoma, N. Total Venous Control and Vein-to-the-Right Superior Mesenteric Artery Approach in Robotic Pancreatoduodenectomy. Annals of surgical oncology 31(13):8721-8722, 2024. e-Pub 2024. PMID: 39284994.
37. Stoop, TF, Augustinus, S, Björnsson, B, Tingstedt, B, Andersson, B, Wolfgang, CL, Werner, J, Johansen, K, Stommel, MW, Katz, MH, Ghadimi, MB, House, MG, Ghorbani, P, Molenaar, IQ, De Wilde, RF, Mieog, S, Keck, T, Wellner, U, Uhl, W, Besselink, MG, Pitt, HA, Chiaro, MD. ASO Visual Abstract. Annals of surgical oncology 31(13):8768-8769, 2024. e-Pub 2024. PMID: 39402315.
38. Ludmir, EB, Sherry, AD, Fellman, B, Liu, S, Bathala, TK, Haymaker, CL, Medina-Rosales, M, Reuben, A, Holliday, EB, Smith, GL, Noticewala, SS, Nicholas, S, Price, TR, Martin, RM, Perles, LA, Lee, SS, Lee, MS, Smaglo, BG, Huey, RW, Willis, JA, Zhao, D, Cohen, L, Taniguchi, C, Koay, EJ, Katz, MH, Wolff, RA, Das, P, Pant, S, Koong, A, Tang, C. Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND). Journal of Clinical Oncology 42(32):3795-3805, 2024. e-Pub 2024. PMID: 39102622.
39. Stoop, TF, Augustinus, S, Björnsson, B, Tingstedt, B, Andersson, B, Wolfgang, CL, Werner, J, Johansen, K, Stommel, MW, Katz, MH, Ghadimi, MB, House, MG, Ghorbani, P, Molenaar, IQ, De Wilde, RF, Mieog, S, Keck, T, Wellner, U, Uhl, W, Besselink, MG, Pitt, HA, Chiaro, MD, Dierenvan Dieren, S, Rodriguez Franco, S, Mackay, TM. Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma. Annals of surgical oncology 31(12):8327-8339, 2024. e-Pub 2024. PMID: 39120839.
40. Stoop, TF, Augustinus, S, Andersson, B, Ghorbani, P, Wellner, U, Uhl, W, Besselink, MG, Pitt, HA, Chiaro, MD, van Dieren, S, Rodriguez Franco, S, Mackay, TM, Keck, T, Mieog, S, De Wilde, RF, Molenaar, IQ, House, MG, Ghadimi, MB, Katz, MH, Stommel, MW, Johansen, K, Werner, J, Wolfgang, CL, Tingstedt, B, Björnsson, B. ASO Author Reflections. Annals of surgical oncology 31(12):8354-8355, 2024. e-Pub 2024. PMID: 39158637.
41. Balachandran Pillai A, Yousef M, Yousef A, Alfaro-Munoz KD, Smaglo BG, Willis J, Wolff RA, Pant S, Hurd MW, Maitra A, Wang H, Katz MHG, Prakash LR, Tzeng CD, Snyder R, Castelnovo LF, Chen A, Kravets A, Kudriavtseva K, Tarasov A, Kryukov K, Ying H, Shen JP, Zhao D. Molecular and Clinical Features of Pancreatic Acinar Cell Carcinoma: A Single-Institution Case Series. Cancers (Basel) 16(19), 2024. e-Pub 2024. PMID: 39410042.
42. Taherian, M, Katz, MH, Prakash, L, Wei, D, Tong, YT, Lai, Z, Chatterjee, D, Wang, H, Kim, M, Tzeng, CD, Ikoma, N, Wolff, RA, Zhao, D, Koay, EJ, Maitra, A, Wang, H. The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Cancers 16(19), 2024. e-Pub 2024.
43. Zaveri S, Teshome M, Reyna C, Francescatti AB, Yi M, Katz MHG, Hunt KK, Vreeland T. Assessing Surgeon Familiarity with the Commission on Cancer Operative Standards for Cancer Surgery. Ann Surg Oncol 31(10):6378-6386, 2024. e-Pub 2024. PMID: 39090487.
44. Zaveri S, Teshome M, Katz MHG, Hunt KK, Vreeland T. ASO Author Reflections: The Path to Standardizing Surgical Cancer Care in the USA. Ann Surg Oncol 31(10):6406-6407, 2024. e-Pub 2024. PMID: 39090490.
45. Snyder RA, Zemla TJ, Shi Q, Segovia D, Ahmad SA, O'Reilly EM, Herman JM, Katz MHG. Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery for Borderline Resectable Pancreatic Cancer in a Phase 2 Clinical Trial (Alliance A021501). Ann Surg Oncol 31(10):7033-7042, 2024. e-Pub 2024. PMID: 39008208.
46. Taherian M, Katz MHG, Prakash LR, Wei D, Tong YT, Lai Z, Chatterjee D, Wang H, Kim M, Tzeng CD, Ikoma N, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang H. The Association between Sampling and Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Cancers (Basel) 16(19), 2024. e-Pub 2024. PMID: 39409932.
47. Boggi, U, Kauffmann, E, Napoli, N, Barreto, SG, Besselink, MG, Fusai, G, Hackert, T, Hilal, MA, Marchegiani, G, Salvia, R, Shrikhande, SV, Truty, MA, Werner, J, Wolfgang, CL, Bannone, E, Capretti, G, Cattelani, A, Coppola, A, Cucchetti, A, De Sio, D, Di Dato, A, Di Meo, G, Fiorillo, C, Gianfaldoni, C, Ginesini, M, Hidalgo Salinas, C, Lai, Q, Miccoli, M, Montorsi, R, Pagnanelli, M, Poli, A, Ricci, C, Sucameli, F, Tamburrino, D, Viti, V, Cameron, JL, Clavien, PA, Asbun, HJ, Volterran, D, Vasile, E, Tortora, G, Silvestris, N, Rotondo, MI, Reni, M, Paiar, F, Neri, E, MUTIGNANI, M, Morganti, AG, Masi, G, Katz, MH. REDISCOVER guidelines for borderline-resectable and locally advanced pancreatic cancer. Updates in Surgery 76(5):1573-1591, 2024. e-Pub 2024. PMID: 38684573.
48. Lu PW, Lyu HG, Prakash LR, Chiang YS, Maxwell JE, Snyder RA, Kim MP, Tzeng CD, Katz MHG, Ikoma N. Effect of surgical approach on early return to intended oncologic therapy after resection for pancreatic ductal adenocarcinoma. Surg Endosc 38(9):4986-4995, 2024. e-Pub 2024. PMID: 38987482.
49. Mohindroo C, Baydogan S, Agarwal P, Wright RD, Prakash LR, Mork ME, Klein AP, Laheru DA, Maxwell JE, Katz MHG, Dasari A, Kim MP, He J, McAllister F, De Jesus-Acosta A. Germline Testing Identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors. Cancer Prev Res (Phila) 17(7):335-342, 2024. e-Pub 2024. PMID: 38662083.
50. Boggi U, Kauffmann E, Napoli N, Barreto SG, Besselink MG, Fusai GK, Hackert T, Abu Hilal M, Marchegiani G, Salvia R, Shrikhande SV, Truty M, Werner J, Wolfgang CL, Bannone E, Capretti G, Cattelani A, Coppola A, Cucchetti A, De Sio D, Di Dato A, Di Meo G, Fiorillo C, Gianfaldoni C, Ginesini M, Hidalgo Salinas C, Lai Q, Miccoli M, Montorsi R, Pagnanelli M, Poli A, Ricci C, Sucameli F, Tamburrino D, Viti V, Addeo PF, Alfieri S, Bachellier P, Baiocchi GL, Balzano G, Barbarello L, Brolese A, Busquets J, Butturini G, Caniglia F, Caputo D, Casadei R, Chunhua X, Colangelo E, Coratti A, Costa F, Crafa F, Dalla Valle R, De Carlis L, de Wilde RF, Del Chiaro M, Di Benedetto F, Di Sebastiano P, Dokmak S, Hogg M, Egorov VI, Ercolani G, Ettorre GM, Falconi M, Ferrari G, Ferrero A, Filauro M, Giardino A, Grazi GL, Gruttadauria S, Izbicki JR, Jovine E, Katz M, Keck T, Khatkov I, Kiguchi G, Kooby D, Lang H, Lombardo C, Malleo G, Massani M, Mazzaferro V, Memeo R, Miao Y, Mishima K, Molino C, Nagakawa Y, Nakamura M, Nardo B, Panaro F, Pasquali C, Perrone V, Rangelova E, Liu R, Romagnoli R, Romito R, Rosso E, Schulick R, Siriwardena A, Spampinato MG, Strobel O, Testini M, Troisi RI, Uzunoglo FG, Valente R, Veneroni L, Zerbi A, Vicente E, Vistoli F, Vivarelli M, Wakabayashi G, Zanus G, Zureikat A, Zyromski NJ, Coppola R, D'Andrea V, Davide J, Dervenis C, Frigerio I, Konlon KC, Michelassi F, Montorsi M, Nealon W, Portolani N, Sousa Silva D, Bozzi G, Ferrari V, Trivella MG, Cameron J, Clavien PA, Asbun HJ, Advisory Board RM. REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer. Ann Surg 280(1):56-65, 2024. e-Pub 2024. PMID: 38407228.
51. Martin AN, Newhook TE, Arvide EM, Kim BJ, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Chun YS, Katz MH, Vauthey JN, Tzeng CD. Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg 233:17-23, 2024. e-Pub 2024. PMID: 38129274.
52. Hirata Y, To C, Lyu H, Smith GL, Samuel JP, Tran Cao HS, Badgwell BD, Katz MHG, Ikoma N. Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy. Ann Surg Oncol 31(7):4361-4370, 2024. e-Pub 2024. PMID: 38536586.
53. Shi C, De B, Tran Cao HS, Liu S, Florez MA, Kouzy R, Grippin AJ, Katz MHG, Tzeng CD, Ikoma N, Kim MP, Lee S, Willis J, Noticewala SS, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Ludmir EB, Koay EJ. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Cancer Med 13(12):e7434, 2024. e-Pub 2024. PMID: 38923407.
54. Ngo-Huang AT, Parker NH, Schadler KL, Katz MHG. Response to: Comment on "Effects of a Pragmatic Home-Based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial". Ann Surg Open 5(2):e435, 2024. e-Pub 2024. PMID: 38911649.
55. Cass SH, Williams LA, Rajaram R, Hirata Y, Rice D, Tzeng CD, Katz MHG, Badgwell BD, Wang XS, Ikoma N. Patient-reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study. J Surg Oncol. e-Pub 2024. PMID: 38798277.
56. Azimuddin A, Tzeng CD, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Newhook TE, Kim MP, Ikoma N, Snyder RA, Lee JE, Perrier ND, Katz MH, Maxwell JE. Postoperative Global Period Cost Reduction Using 3 Successive Risk-Stratified Pancreatectomy Clinical Pathways. J Am Coll Surg 238(4):451-459, 2024. e-Pub 2024. PMID: 38180055.
57. Hirata Y, Lyu H, Smith GL, Wang XS, Tran Cao HS, Katz MHG, Ikoma N. What Defines the Value of Minimally Invasive Surgery for Cancer Patients?. Ann Surg Oncol 31(4):2204-2207, 2024. e-Pub 2024. PMID: 38123730.
58. Cass SH, Tzeng CD, Prakash LR, Maxwell J, Snyder RA, Kim MP, Huey RW, Smaglo BG, Pant S, Koay EJ, Wolff RA, Lee JE, Katz MHG, Ikoma N. Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer. Ann Surg. e-Pub 2024. PMID: 38506042.
59. Tchelebi LT, Segovia D, Smith K, Shi Q, Fitzgerald TJ, Chuong MD, Zemla TJ, O'Reilly EM, Meyerhardt JA, Koay EJ, Lowenstein J, Shergill A, Katz MHG, Herman JM. Radiation Therapy Quality Assurance Analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Pancreas. Int J Radiat Oncol Biol Phys. e-Pub 2024. PMID: 38492812.
60. Theijse RT, Stoop TF, Janssen QP, Prakash LR, Katz MHG, Doppenberg D, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG. Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study. Br J Surg 111(3), 2024. e-Pub 2024. PMID: 38456678.
61. Doppenberg, D, Stoop, TF, van Dieren, S, Katz, MH, Janssen, QP, Nasar, N, Prakash, L, Theijse, R, Tzeng, CD, Wei, A, Zureikat, AH, Koerkamp, BG, Besselink, MG. ASO Visual Abstract. Annals of surgical oncology 31(3):1954-1955, 2024. e-Pub 2024. PMID: 38102327.
62. Baydogan S, Mohindroo C, Hasanov M, Montiel MF, Quesada P, Cazacu IM, Luzuriaga Chavez AA, Mork ME, Dong W, Feng L, You YN, Arun B, Vilar E, Brown P, Katz MHG, Chari ST, Maitra A, Tamm EP, Kim MP, Bhutani MS, McAllister F. New-onset diabetes is a predictive risk factor for pancreatic lesions in high-risk individuals: An observational cohort study. Endosc Ultrasound 13(2):83-88, 2024. e-Pub 2024. PMID: 38947744.
63. Stoop TF, Doppenberg D, Katz MHG, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG, Surgery Consortium TP. ASO Author Reflections: The Value of Serum CEA for Prognostication at Staging and Response Evaluation in Patients with Localized Pancreatic Adenocarcinoma and Nonelevated CA19-9. Ann Surg Oncol 31(3):1842-1843, 2024. e-Pub 2024. PMID: 38182848.
64. Doppenberg D, Stoop TF, van Dieren S, Katz MHG, Janssen QP, Nasar N, Prakash LR, Theijse RT, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Besselink MG, Surgery Consortium TP. Serum CEA as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial Treatment: A TAPS Consortium Study. Ann Surg Oncol 31(3):1919-1932, 2024. e-Pub 2024. PMID: 38170408.
65. Taylor JS, Fellman BM, Raty S, Lasala J, Iniesta MD, Cain KE, Horner AA, Bruno M, Folloder JP, Knippel SL, Khanh V, Popovich S, Katz MHG, Best C, Thosani S. Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center. Ann Surg Oncol. e-Pub 2024. PMID: 38347330.
66. Dekker EN, van Dam JL, Janssen QP, Besselink MG, DeSilva A, Doppenberg D, van Eijck CHJ, Nasar N, O'Reilly EM, Paniccia A, Prakash LR, Tzeng CD, Verkolf EMM, Wei AC, Zureikat AH, Katz MHG, Groot Koerkamp B, Surgery Consortium TP. Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study. J Clin Oncol:JCO2301311. e-Pub 2024. PMID: 38315954.
67. Yousef A, Yousef M, Chowdhury S, Abdilleh K, Knafl M, Edelkamp P, Alfaro-Munoz K, Chacko R, Peterson J, Smaglo BG, Wolff RA, Pant S, Lee MS, Willis J, Overman M, Doss S, Matrisian L, Hurd MW, Snyder R, Katz MHG, Wang H, Maitra A, Shen JP, Zhao D. Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma. NPJ Precis Oncol 8(1):27, 2024. e-Pub 2024. PMID: 38310130.
68. Ludmir, EB, Sherry, AD, Fellman, B, Liu, S, Bathala, TK, Haymaker, CL, Medina-Rosales, M, Holliday, EB, Smith, GL, Lee, MS, Zhao, D, Smaglo, BG, Taniguchi, C, Koay, EJ, Katz, MH, Wolff, RA, Das, P, Pant, S, Koong, A, Tang, C. Addition of metastasis-directed therapy to standard-of-care systemic therapy for oligometastatic pancreatic ductal adenocarcinoma (EXTEND). Journal of Clinical Oncology 42(3), 2024. e-Pub 2024.
69. Thomas, KK, Francescatti, A, Vreeland, TJ, Teshome, M, Morris, AM, Hunt, KK, Katz, MH, Villano, AM. ASO Visual Abstract. Annals of surgical oncology 31(1):72-73, 2024. e-Pub 2024. PMID: 37914924.
70. Yousef, M, Hurd, MW, Yousef, A, Snyder, RA, Knafl, M, Fanaeian, M, Chacko, R, Peterson, J, Smaglo, BG, Wolff, RA, Pant, S, Lee, MS, Overman, MJ, Tzeng, CD, Katz, MH, Wang, H, Maitra, A, Ludmir, EB, Shen, JY, Zhao, D. Frequency and oncologic outcomes of KRAS mutations in circulating tumor DNA of patients with pancreatic ductal adenocarcinoma. Journal of Clinical Oncology 42(3_suppl):636, 2024. e-Pub 2024.
71. Snyder, RA, Zemla, TJ, Shi, Q, Segovia, D, Ahmad, SA, O'Reilly, EM, Herman, JM, Katz, MH. Postoperative complications following neoadjuvant therapy and surgery in a phase 2 borderline resectable pancreatic cancer clinical trial (Alliance A021501). Journal of Clinical Oncology 42(3):664, 2024. e-Pub 2024.
72. Hirata Y, Gottumukkala V, Ajith J, Schmeisser JA, Ninan EP, Maxwell JE, Snyder RA, Kim MP, Tran Cao HS, Tzeng CD, Badgwell BD, Katz MHG, Ikoma N. Laparoscopic transverse abdominis plane block: how I do it and a cost efficiency analysis. Langenbecks Arch Surg 409(1):16, 2023. e-Pub 2023. PMID: 38147123.
73. Katz MHG, Petroni GR, Bauer T, Reilley MJ, Wolpin BM, Stucky CC, Bekaii-Saab TS, Elias R, Merchant N, Dias Costa A, Lenehan P, Cardot-Ruffino V, Rodig S, Pfaff K, Dougan SK, Nowak JA, Varadhachary GR, Slingluff CL, Rahma O. Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma. J Immunother Cancer 11(12), 2023. e-Pub 2023. PMID: 38040420.
74. Taniguchi CM, Frakes JM, Aguilera TA, Palta M, Czito B, Bhutani MS, Colbert LE, Abi Jaoude J, Bernard V, Pant S, Tzeng CD, Kim DW, Malafa M, Costello J, Mathew G, Rebueno N, Koay EJ, Das P, Ludmir EB, Katz MHG, Wolff RA, Beddar S, Sawakuchi GO, Moningi S, Slack Tidwell RS, Yuan Y, Thall PF, Beardsley RA, Holmlund J, Herman JM, Hoffe SE. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. Lancet Oncol 24(12):1387-1398, 2023. e-Pub 2023. PMID: 38039992.
75. Boyev A, Azimuddin A, Newhook TE, Maxwell JE, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Evaluation and Recalibration of Risk-Stratified Pancreatoduodenectomy Drain Fluid Amylase Removal Criteria. J Gastrointest Surg 27(12):2806-2814, 2023. e-Pub 2023. PMID: 37935998.
76. Boyev A, Azimuddin A, Prakash LR, Newhook TE, Maxwell JE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Katz MHG, Tzeng CD. Classification of Post-Pancreatectomy Readmissions and Opportunities for Targeted Mitigation Strategies. Annals of Surgery, 2023. e-Pub 2023. PMID: 37791481.
77. Mathew M, Virarkar M, Sun J, Thai K, Saleh M, Menendez-Santos M, Bedi D, Lee JE, Katz M, Kundra V, Bhosale P. Real-Time Ultrasound-Computed Tomography Fusion with Volume Navigation to Assess Pancreatic Cystic Lesions. Curr Oncol 30(9):8375-8385, 2023. e-Pub 2023. PMID: 37754523.
78. PD- blockade induces reactivation of non-productive T cell responses characterized by NF-kB signaling in patients with pancreatic cancer Ali LR, Lenehan PJ, Cardot-Ruffino V, Dias Costa A, Katz MHG, Bauer TW, Nowak JA, Wolpin BM, Abrams TA, Patel A, Clancy TE, Wang J, Mancias JD, Reilley MJ, Stucky CH, Bekaii-Saab TS, Elias R, Merchant N, Slingluff CL, Rahma OE, Dougan SK. PD-1 blockade induces reactivation of non-productive T cell responses characterized by NF-kB signaling in patients with pancreatic cancer. Clinical Cancer Research 30(3):542-553, 2023. e-Pub 2023. PMID: 37733830.
79. Boyev A, Prakash LR, Chiang YJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Tzeng CD, Katz MHG, Maxwell JE. Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinoma. Surgical Oncology 51, 2023. e-Pub 2023. PMID: 37742542.
80. Boyev A, Jain AJ, Newhook TE, Prakash LR, Chiang YJ, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Maxwell JE, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Opioid-Free Discharge After Pancreatic Resection Through a Learning Health System Paradigm. JAMA Surgery 158(11):E234154, 2023. e-Pub 2023. PMID: 37672236.
81. Yousef A, Yousef M, Chowdhury S, Abdilleh K, Knafl M, Edelkamp P, Alfaro-Munoz K, Chacko R, Peterson J, Smaglo BG, Wolff RA, Pant S, Lee MS, Willis J, Overman M, Doss S, Matrisian L, Hurd MW, Snyder R, Katz MHG, Wang H, Maitra A, Shen JP, Zhao D. Impact of KRAS Mutations and Co-mutations on Clinical Outcomes in Pancreatic Ductal Adenocarcinoma. Research Square, 2023. e-Pub 2023. PMID: 37609177.
82. Ayabe RI, Prakash LR, Bruno ML, Newhook TE, Maxwell JE, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Differential Gains in Surgical Outcomes for High-Risk vs Low-Risk Pancreatoduodenectomy with Successive Refinements of Risk-Stratified Care Pathways. J Am Coll Surg 237(1):4-12, 2023. e-Pub 2023. PMID: 36786469.
83. Eshmuminov D, Aminjonov B, Palm RF, Malleo G, Schmocker RK, Abdallah R, Yoo C, Shaib WL, Schneider MA, Rangelova E, Choi YJ, Kim H, Rose JB, Patel S, Wilson GC, Maloney S, Timmermann L, Sahora K, Rössler F, Lopez-Lopez V, Boyer E, Maggino L, Malinka T, Park JY, Katz MHG, Prakash L, Ahmad SA, Helton S, Jang JY, Hoffe SE, Salvia R, Taieb J, He J, Clavien PA, Held U, Lehmann K. FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review. Ann Surg Oncol 30(7):4417-4428, 2023. e-Pub 2023. PMID: 37020094.
84. Zhang Y, Wang H, Overman M, Katz MH, Wang H. Prognostic Significance of Trophoblastic Cell Surface Antigen 2 Expression and Pathologic Parameters in Patients with Ampullary Adenocarcinoma. Human Pathology 139:117-125, 2023. e-Pub 2023. PMID: 37516386.
85. Boyev A, Arvide EM, Newhook TE, Prakash LR, Bruno ML, Dewhurst WL, Kim MP, Maxwell JE, Ikoma N, Snyder RA, Lee JE, Katz MHG, Tzeng CD. Prophylactic Antibiotic Duration and Infectious Complications in Pancreatoduodenectomy Patients with Biliary Stents: Opportunity for De-Escalation. Annals of Surgery, 2023. e-Pub 2023. PMID: 37389897.
86. Boyev A, Prakash LR, Chiang YJ, Childers CP, Jain AJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Katz MHG, Tzeng CD, Maxwell JEBoyev A, Prakash LR, Chiang YJ, Childers CP, Jain AJ, Newhook TE, Bruno ML, Arvide EM, Dewhurst WL, Kim MP, Ikoma N, Lee JE, Snyder RA, Katz MHG, Tzeng CD, Maxwell JE. Postoperative Opioid Use Is Associated with Increased Rates of Grade B/C Pancreatic Fistula After Distal Pancreatectomy. Journal of Gastrointestinal Surgery 27(10):2135-2144, 2023. e-Pub 2023. PMID: 37468733.
87. Snyder RA, Dueck AC, Fruth B, Shi Q, Hubbard JM, Herman JM, O'Reilly EM, Katz MHG. Patient-Reported Adverse Events During Neoadjuvant Therapy in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501). Annals of Surgery 278(4):598-608, 2023. e-Pub 2023. PMID: 37334719.
88. Spitzer HV, Kemp Bohan PM, Carpenter EL, Adams AM, Chang SC, Grunkemeier G, Vreeland TJ, Tzeng CD, Katz MHG, Nelson DW. Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Nonmetastatic Pancreatic Adenocarcinoma. Annals of Surgical Oncology 30(11):6662-6670, 2023. e-Pub 2023. PMID: 37330447.
89. Liang TZ, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Ikoma N, Wolff RA, Zhao D, Koay EJ, Maitra A, Kundu S, Wang H. Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy. Cancers (Basel), 2023. e-Pub 2023. PMID: 37370842.
90. Zaveri S, Lillemoe HA, Teshome M, Reyna CR, Vreeland TJ, Francescatti AB, Zheng L, Hunt KK, Katz MHG, Kilgore LJ. Operative standards for sentinel lymph node biopsy and axillary lymphadenectomy for breast cancer: review of the American College of Surgeons commission on cancer standards 5.3 and 5.4. Surgery 174(3):717-721, 2023. e-Pub 2023. PMID: 37202308.
91. Springfeld C, Ferrone CR, Katz MHG, Philip PA, Hong TS, Hackert T, Büchler MW, Neoptolemos J. Neoadjuvant therapy for pancreatic cancer. Nat Rev Clin Oncol 20(5):318-337, 2023. e-Pub 2023. PMID: 36932224.
92. Tong YT, Lai Z, Katz MHG, Prakash LR, Wang H, Chatterjee D, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Maitra A, Wang H. Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy. Cancers (Basel) 15(9):2608, 2023. e-Pub 2023. PMID: 37174073.
93. Hirata Y, Maxwell JE, Kim MP, Tzeng CD, Katz MHG, Ikoma N. Transmesocolic Approach for Robotic Duodenal Operations. Ann Surg Oncol 30(5):2959, 2023. e-Pub 2023. PMID: 36752968.
94. Sohn AJ, Taherian M, Katz MHG, Prakash LR, Chatterjee D, Wang H, Kim M, Tzeng CD, Lee JE, Ikoma N, Rashid A, Wolff RA, Zhao D, Koay EJ, Sun R, Maitra A, Wang H. Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy. Am J Surg Pathol 47(4):421-430, 2023. e-Pub 2023. PMID: 36746143.
95. Witt RG, Hirata Y, Prakash LR, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Lee JE, Vauthey JN, Katz MHG, Tzeng CD, Ikoma N. Comparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci 30(4):523-531, 2023. e-Pub 2023. PMID: 35796581.
96. Ngo-Huang AT, Parker NH, Xiao LC, Schadler KL, Petzel MQB, Prakash LR, Kim MP, Tzeng CD, Lee JE, Ikoma N, Wolff RA, Javle MM, Koay EJ, Pant SD, Folloder JP, Wang X, Cotto AM, Ju YR, Garg N, Wang H, Bruera ED, Basen-Engquist KM, Katz MHG. Effects of a Pragmatic Home-based Exercise Program Concurrent with Neoadjuvant Therapy on Physical Function of Patients with Pancreatic Cancer: The Pancfit Randomized Clinical Trial. Ann Surg 278(1):22-30. e-Pub 2023. PMID: 37026453.
97. Newhook TE, Vreeland TJ, Griffin JF, Tidwell RSS, Prakash LR, Koay EJ, Ludmir EB, Smaglo BG, Pant S, Overman M, Wolff RA, Ikoma N, Maxwell J, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma. Ann Surg 277(3):484-490, 2023. e-Pub 2023. PMID: 36649067.
98. Hester CA, Kothari AN, Mason M, Maxwell J, Ikoma N, Kim MP, Tzeng CD, Lee JE, Katz MHG, Cao HST. Surgical eligibility does not imply surgical equity: recommendations for curative treatment in patients with stage I/II pancreatic head adenocarcinoma differ by age and race. Ann Surg 277(2):321-328, 2023. e-Pub 2023. PMID: 34183508.
99. Lillemoe HA, Williams JK, Teshome MK, Zheng L, Francescatti AB, Hieken TJ, Katz MH, Hunt KH, Vreeland TJ, Asare EA. Setting the Standard for Cutaneous Melanoma Wide Local Excision: An Overview of the American College of Surgeons Commission on Cancer Standard 5.5. Journal of the American College of Surgeons 236(2):424-428, 2023. e-Pub 2023. PMID: 36648270.
100. Donovan EC, Prakash LR, Chiang YJ, Bruno ML, Maxwell JE, Ikoma N, Tzeng CD, Katz MHG, Lee JE, Kim MP. Incidence of Postoperative Complications Following Pancreatectomy for Pancreatic Cystic Lesions or Pancreatic Cancer. J Gastrointest Surg 27(2):319-327, 2023. e-Pub 2023. PMID: 36443557.
101. Emelogu IK, Campbell DR, Lanke G, Yu AC, Nogueras-Gonzalez G, Lum P, Coronel E, Ge PS, Ross WA, Weston BR, Katz MH, Lee JH. A decade's experience of managing suspected pancreatic adenocarcinoma at a tertiary cancer center. Annals of Gastroenterology 36(1):81-86, 2023. e-Pub 2023. PMID: 36593816.
102. Martin AN, Concors SJ, Kim BJ, Newhook TE, Arvide EM, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Katz MHG, Vauthey JN, Tzeng CD. Individual components of post-hepatectomy care pathways have differential impacts on length of stay. Am J Surg 225(1):53-57, 2023. e-Pub 2023. PMID: 36207173.
103. Snyder RA, Katz MHG. Fundamentals of Conducting Cooperative Group Trials Through the National Clinical Trials Network. Surg Oncol Clin N Am 32(1):1-12, 2023. e-Pub 2023. PMID: 36410910.
104. Ikoma N, Seo YD, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Katz MHG. Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci 30(1):e1-e2, 2023. e-Pub 2023. PMID: 35950790.
105. Hester CA, Katz MHG. A patient-centered, multidisciplinary approach to treating borderline resectable pancreatic adenocarcinoma. Chin Clin Oncol 11(6):45, 2022. e-Pub 2022. PMID: 36509553.
106. Erstad DJ, Hatanaka Y, Cass S, Maxwell J, Tran Cao H, Kim M, Tzeng CW, Lee JE, Katz M, Ikoma N. Technique for Robotic Pancreaticojejunostomy. Journal of the American College of Surgeons 236(5):e12-e14, 2022. e-Pub 2022. PMID: 36729595.
107. DiPeri TP, Newhook TE, Prakash LR, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Prognostic significance of preoperative and postoperative CA 19-9 normalization in pancreatic adenocarcinoma treated with neoadjuvant therapy or surgery first. J Surg Oncol 126(6):1021-1027, 2022. e-Pub 2022. PMID: 35726394.
108. Schalck A, Sakellariou-Thompson D, Forget MA, Sei E, Hughes TG, Reuben A, Bai S, Hu M, Kumar T, Hurd MW, Katz MHG, Tzeng CD, Pant S, Javle M, Fogelman DR, Maitra A, Haymaker CL, Kim MP, Navin NE, Bernatchez C. Single cell sequencing reveals trajectory of tumor-infiltrating lymphocyte states in pancreatic cancer. Cancer Discov 12(10):2330-2349, 2022. e-Pub 2022. PMID: 35849783.
109. Katz MHG, Francescatti AB, Hunt KK, of Surgeons CSSPOTAC. Technical Standards for Cancer Surgery: Commission on Cancer Standards 5.3-5.8. Ann Surg Oncol 29(11):6549-6558, 2022. e-Pub 2022. PMID: 35187620.
110. Kang Y, Deng J, Ling J, Li X, Chiang YJ, Koay EJ, Wang H, Burks JK, Chiao PJ, Hurd MW, Bhutani MS, Lee JH, Weston BR, Maitra A, Ikoma N, Tzeng CD, Lee JE, DePinho RA, Wolff RA, Pant S, McAllister F, Katz MH, Fleming JB, Kim MP. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma. Journal of Clinical Investigation 132(24):e151604, 2022. e-Pub 2022. PMID: 36282600.
111. DiPeri TP, Newhook TE, Tran Cao HS, Ikoma N, Dewhurst WL, Arvide EM, Bruno ML, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Opioid Discharge Prescriptions After Inpatient Surgery: Risks of Rebound Refills by Length of Stay. J Surg Res 278:111-118, 2022. e-Pub 2022. PMID: 35597025.
112. Allen CJ, Smith GL, Prakash L, Volk RJ, Ikoma N, Aloia TA, Gottumukkala V, Katz MHG. What is "Value"? Results of a Survey of Cancer Patients and Providers. Ann Surg Oncol 29(11):6537-6545, 2022. e-Pub 2022. PMID: 35391609.
113. Katz MHG, Shi Q, Meyers J, Herman JM, Chuong M, Wolpin BM, Ahmad S, Marsh R, Schwartz L, Behr S, Frankel WL, Collisson E, Leenstra J, Williams TM, Vaccaro G, Venook A, Meyerhardt JA, O'Reilly EM. Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial. JAMA Oncol 8(9):1263-1270, 2022. e-Pub 2022. PMID: 35834226.
114. Wang CX, Elganainy D, Zaid MM, Butner JD, Agrawal A, Nizzero S, Minsky BD, Holliday EB, Taniguchi CM, Smith GL, Koong AC, Herman JM, Das P, Maitra A, Wang H, Wolff RA, Katz MHG, Crane CH, Cristini V, Koay EJ. Mass transport model of radiation response: calibration and application to chemoradiation for pancreatic cancer. Int J Radiat Oncol Biol Phys 114(1):163-172, 2022. e-Pub 2022. PMID: 35643254.
115. Hester CA, Perri G, Prakash LR, Maxwell JE, Ikoma N, Kim MP, Tzeng CD, Smaglo B, Wolff R, Javle M, Overman MJ, Lee JE, Katz MHG. Radiographic and Serologic Response to First-Line Chemotherapy in Unresected Localized Pancreatic Cancer. J Natl Compr Canc Netw 20(8):887-897, 2022. e-Pub 2022. PMID: 35948035.
116. Kurz E, Hirsch CA, Dalton T, Shadaloey SA, Khodadadi-Jamayran A, Miller G, Pareek S, Rajaei H, Mohindroo C, Baydogan S, Ngo-Huang A, Parker N, Katz MHG, Petzel M, Vucic E, McAllister F, Schadler K, Winograd R, Bar-Sagi D. Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer. Cancer Cell 40(7):720-737.e5, 2022. e-Pub 2022. PMID: 35660135.
117. Uppal A, Kothari AN, Scally CP, Roland CL, Bednarski BK, Katz MHG, Vauthey JN, Chang GJ, Team D. Adoption of Telemedicine for Postoperative Follow-Up After Inpatient Cancer-Related Surgery. JCO Oncol Pract 18(7):e1091-e1099, 2022. e-Pub 2022. PMID: 35263166.
118. Kim BJ, Arvide EM, Gaskill C, Martin AN, Kawaguchi Y, Chiang YJ, Dewhurst WL, Phan TL, Tran Cao HS, Chun YS, Katz MHG, Vauthey JN, Tzeng CD, Newhook TE. Risk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay. Surg Open Sci 9:109-116, 2022. e-Pub 2022. PMID: 35747509.
119. Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Jacobson G, Wolff RA, Overman M, Varadhachary G, Pant S, Wang H, Tzeng CW, Ikoma N, Kim M, Lee JE, Katz MH, Tamm E, Bhosale P, Taniguchi CM, Holliday EB, Smith GL, Ludmir EB, Minsky BD, Crane CH, Koong AC, Das P, Wang X, Javle M, Krishnan S. Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. Int J Radiat Oncol Biol Phys 114(3):444-453, 2022. e-Pub 2022. PMID: 35863672.
120. Janssen QP, van Dam JL, Prakash LR, Doppenberg D, Crane CH, van Eijck CHJ, Ellsworth SG, Jarnagin WR, O'Reilly EM, Paniccia A, Reyngold M, Besselink MG, Katz MHG, Tzeng CD, Zureikat AH, Groot Koerkamp B, Wei AC, Surgery Consortium TP. Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study. J Natl Compr Canc Netw 20(7):783-791, 2022. e-Pub 2022. PMID: 35830887.
121. Witt RG, Newhook TE, Prakash LR, Bruno ML, Arvide EM, Dewhurst WL, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After Pancreatectomy. J Surg Res 275:244-251, 2022. e-Pub 2022. PMID: 35306260.
122. DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, Consortium P. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
123. Monberg ME, Geiger H, Lee JJ, Sharma R, Semaan A, Bernard V, Wong J, Wang F, Liang S, Swartzlander DB, Stephens BM, Katz MHG, Chen K, Robine N, Guerrero PA, Maitra A. Occult polyclonality of preclinical pancreatic cancer models drives in vitro evolution. Nat Commun 13(1):3652, 2022. e-Pub 2022. PMID: 35752636.
124. Adams AM, Vreeland TJ, Teshome M, Francescatti AB, Zheng L, Hunt KK, Katz MHG, Messick CA. American College of Surgeons Commission on Cancer Standard 5.7 for Total Mesorectal Excision for Mid-to-Low Rectal Cancer. J Am Coll Surg 234(6):1249-1253, 2022. e-Pub 2022. PMID: 35703824.
125. Lee JH, Yu AC, Ali FS, Ahmed O, Lynch P, Ge P, Coronel E, Kim M, Coronel M, Folloder J, Katz MHG. The conundrum in endoscopic management of duodenal polyps: a tertiary cancer center experience. Expert Rev Gastroenterol Hepatol 16(6):569-576, 2022. e-Pub 2022. PMID: 35687675.
126. Janssen QP, van Dam JL, Doppenberg D, Prakash LR, van Eijck CHJ, Jarnagin WR, O' Reilly EM, Paniccia A, Besselink MG, Katz MHG, Tzeng CD, Wei AC, Zureikat AH, Groot Koerkamp B, Surgery Consortium TP. FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium. J Natl Cancer Inst 114(5):695-703, 2022. e-Pub 2022. PMID: 35157075.
127. Hirata Y, Katz MHG, Ikoma N. Robotic Duodenojejunostomy Bypass for Metastatic Pancreatic Body Cancer. J Gastrointest Surg 26(5):1115-1116, 2022. e-Pub 2022. PMID: 35132565.
128. Newton AD, Newhook TE, Bruno ML, Prakash L, Chiang YJ, Arango NP, Dewhurst WL, Arvide EM, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy. Journal of Gastrointestinal Surgery 26(5):1054-1062, 2022. e-Pub 2022. PMID: 35023033.
129. Newton AD, Newhook TE, Bruno ML, Prakash L, Chiang YJ, Arango NP, Dewhurst WL, Arvide EM, Ikoma N, Maxwell JE, Kim MP, Lee JE, Katz MHG, Tzeng CD. Iterative Changes in Risk-Stratified Pancreatectomy Clinical Pathways and Accelerated Discharge After Pancreaticoduodenectomy. J Gastrointest Surg 26(5):1054-1062, 2022. e-Pub 2022. PMID: 35023033.
130. Bagley AF, Ludmir EB, Maitra A, Minsky BD, Li Smith G, Das P, Koong AC, Holliday EB, Taniguchi CM, Katz MHG, Tamm EP, Wolff RA, Overman MJ, Patel S, Kim MP, Tzeng CD, Ikoma N, Bhutani MS, Koay EJ. NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience. Clin Transl Radiat Oncol 33(33):66-69, 2022. e-Pub 2022. PMID: 35097226.
131. Elsherif SB, Javadi S, Le O, Lamba N, Katz MHG, Tamm EP, Bhosale PR. Baseline CT-based Radiomic Features Aid Prediction of Nodal Positivity after Neoadjuvant Therapy in Pancreatic Cancer. Radiol Imaging Cancer 4(2):e210068, 2022. e-Pub 2022. PMID: 35333131.
132. Chen Y, Capello M, Rios Perez MV, Vykoukal JV, Roife D, Kang Y, Prakash LR, Katayama H, Irajizad E, Fleury A, Ferri-Borgogno S, Baluya DL, Dennison JB, Do KA, Fiehn O, Maitra A, Wang H, Chiao PJ, Katz MHG, Fleming JB, Hanash SM, Fahrmann JF. CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop. Mol Metab 56:101426, 2022. e-Pub 2022. PMID: 34971802.
133. Vreeland TJ, Bohan PMK, Newhook TE, Allen CJ, Prakash LR, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Contemporary Assessment of Need for Palliative Bypass After Aborted Pancreatoduodenectomy Following Neoadjuvant Therapy. J Gastrointest Surg 26(2):352-359, 2022. e-Pub 2022. PMID: 35064457.
134. Douglas JE, Liu S, Ma J, Wolff RA, Pant S, Maitra A, Tamm EP, Bhosale P, Katz MHG, Varadhachary GR, Koay EJ. PIONEER-Panc: a platform trial for phase II randomized investigations of new and emerging therapies for localized pancreatic cancer. BMC Cancer 22(1):14, 2022. e-Pub 2022. PMID: 34980020.
135. Oppliger FA, Prakash LR, Newhook TE, Chiang YJ, Ikoma N, Maxwell JE, Kim MP, Vauthey JN, Lee JE, Katz MH, Tzeng CD. AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. Surgical Oncology 40, 2021. e-Pub 2021. PMID: 34894620.
136. Wörmann SM, Zhang A, Thege FI, Cowan RW, Rupani DN, Wang R, Manning SL, Gates C, Wu W, Levin-Klein R, Rajapakshe KI, Yu M, Multani AS, Kang Y, Taniguchi CM, Schlacher K, Bellin MD, Katz MHG, Kim MP, Fleming JB, Gallinger S, Maddipati R, Harris RS, Notta F, Ross SR, Maitra A, Rhim AD. APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis. Nature Cancer 2(12):1338-1356, 2021. e-Pub 2021. PMID: 35121902.
137. Newhook TE, Prakash LR, Soliz J, Hancher-Hodges S, Speer BB, Wilks JA, Bruno ML, Dewhurst WL, Arvide EM, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy. Journal of Surgical Oncology 124(8):1381-1389, 2021. e-Pub 2021. PMID: 34398988.
138. Shapiro DD, Soeung M, Perelli L, Dondossola E, Surasi DS, Tripathi DN, Bertocchio JP, Carbone F, Starbuck MW, Van Alstine ML, Rao P, Katz MHG, Parker NH, Shah AY, Carugo A, Heffernan TP, Schadler KL, Logothetis C, Walker CL, Wood CG, Karam JA, Draetta GF, Tannir NM, Genovese G, Msaouel P. Association of high-intensity exercise with renal medullary carcinoma in individuals with sickle cell trait: clinical observations and experimental animal studies. Cancers (Basel) 13(23):6022, 2021. e-Pub 2021. PMID: 34885132.
139. Tong YT, Wang H, Wei D, Prakash LR, Kim M, Tzeng CD, Lee JE, Rashid A, Koay EJ, Wolff RA, Maitra A, Katz MH, Wang H. GRP78 Expression and Prognostic Significance in Patients with Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Therapy vs. Surgery First. Pancreatology 21(7):1378-1385, 2021. e-Pub 2021. PMID: 34429247.
140. Arango NP, Prakash LR, Chiang YJ, Dewhurst WL, Bruno ML, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Risk-Stratified Pancreatectomy Clinical Pathway Implementation and Delayed Gastric Emptying. J Gastrointest Surg 25(9):2221-2230, 2021. e-Pub 2021. PMID: 33236322.
141. Ikoma N, Kim MP, Tran Cao HS, Prakash LP, Maxwell JE, Tzeng CD, Mansfield PF, Lee JE, Badgwell BD, Katz MHG. Early Experience of a Robotic Foregut Surgery Program at a Cancer Center: Video of Shared Steps in Robotic Pancreatoduodenectomy and Gastrectomy. Annals of Surgical Oncology 29(1):285, 2021. e-Pub 2021. PMID: 34515886.
142. Fujii Y, Tzeng CW, Chiang YJ, Halperin DM, Dasari A, Kim MP, Katz MHG, Lee JE, Ikoma N. Incidence of Lymph Node Metastases and Impact of Radical Surgery for Duodenal Neuroendocrine Tumors. Journal of Surgical Research 268:419-431, 2021. e-Pub 2021. PMID: 34416414.
143. Mohindroo C, Hasanov M, Rogers JE, Dong W, Prakash LR, Baydogan S, Mizrahi JD, Overman MJ, Varadhachary GR, Wolff RA, Javle MM, Fogelman DR, Lotze MT, Kim MP, Katz MHG, Pant S, Tzeng CD, McAllister F. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients. Cancer Med 10(15):5041-5050, 2021. e-Pub 2021. PMID: 34250759.
144. White MG, Lee A, Vicente D, Hall C, Kim MP, Katz MHG, Lee JE, Ikoma N, Lucci A, Tzeng CD. Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 8(8):4615-4622, 2021. e-Pub 2021. PMID: 33415562.
145. Marchegiani G, Pollini T, Andrianello S, Tomasoni G, Biancotto M, Javed AA, Kinny-Köster B, Amini N, Han Y, Kim H, Kwon W, Kim M, Perri G, He J, Bassi C, Goh BK, Katz MH, Jang JY, Wolfgang C, Salvia R. Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery. JAMA Surg 156(7):654-661, 2021. e-Pub 2021. PMID: 34009303.
146. Datta J, Wilson GC, D'Angelica MI, Katz MHG, Maithel SK, Merchant NB, Ahmad SA. A Call for Caution in Overinterpreting Exceptional Outcomes Following Radical Surgery for Pancreatic Cancer: Let the Data Speak. Ann Surg 274(1):E82-E84, 2021. e-Pub 2021. PMID: 33086320.
147. Kim BJ, Newhook TE, Blumenthaler A, Chiang YJ, Aloia TA, Roland CL, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years. J Surg Oncol 124(1):143-151, 2021. e-Pub 2021. PMID: 33751605.
148. Deng J, Kang Y, Cheng CC, Li X, Dai B, Katz MH, Men T, Kim MP, Koay E, Huang H, Brekkan RA, Fleming JB. Cancer cell-derived DDR1 mediates collagen type 1-induced neutrophil extracellular traps to promote metastasis in pancreatic ductal adenocarcinoma. JCI Insight 6(17), 2021. e-Pub 2021. PMID: 34237033.
149. Abi Jaoude J, Thunshelle CP, Kouzy R, Nguyen ND, Lin D, Prakash L, Bumanlag IM, Noticewala SS, Niedzielski JS, Beddar S, Ludmir EB, Holliday EB, Das P, Minsky BD, Herman JM, Katz M, Koong AC, Koay EJ, Taniguchi CM. Stereotactic Versus Conventional Radiation Therapy for Patients With Pancreatic Cancer in the Modern Era. Advances in Radiation Oncology 6(6):100763, 2021. e-Pub 2021. PMID: 34934858.
150. Zhang Q, Lu J, Jia M, Ma Y, Sun M, Chen X, Ma X, Yang Y, Kang J, Zhang X, Paiella S, Katz MHG, Tsuchida K, Schattner M, Du S. Evaluation of the reporting quality of clinical practice guidelines on pancreatic cancer using the RIGHT checklist. Ann Transl Med 9(13):1088, 2021. e-Pub 2021. PMID: 34423000.
151. Kothari AN, DiBrito SR, Lee JJ, Caudle AS, Clemens MW, Gottumukkala VN, Katz MHG, Offodile AC, Uppal A, Team D, Chang GJ. Surgical outcomes in cancer patients undergoing elective surgery after recovering from mild-to-moderate SARS-CoV-2 infection. Annals of Surgical Oncology 28(13):8046-8053, 2021. e-Pub 2021. PMID: 34176060.
152. Nissen AP, Vreeland TJ, Teshome M, Archer MA, Francescatti AB, Katz MHG, Hunt KK, Zheng L, Mullett TW. American College of Surgeons Commission on Cancer Standard for Curative Intent Pulmonary Resection. Annals of Thoracic Surgery 113(1):5-8, 2021. e-Pub 2021. PMID: 34119494.
153. Allen CJ, Eska JS, Thaker NG, Feeley TW, Kaplan RS, Huey RW, Tzeng CD, Lee JE, Frank SJ, Aloia TA, Gottumukkala V, Katz MHG. Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative. J Surg Res 262:115-120, 2021. e-Pub 2021. PMID: 33561722.
154. Semaan A, Bernard V, Kim DU, Lee JJ, Huang J, Kamyabi N, Stephens BM, Qiao W, Varadhachary GR, Katz MH, Shen Y, San Lucas FA, Gascoyne P, Alvarez HA, Maitra A, Guerrero PA. Characterisation of circulating tumour cell phenotypes identifies a partial-EMT sub-population for clinical stratification of pancreatic cancer. Br J Cancer 124(12):1970-1977, 2021. e-Pub 2021. PMID: 33785875.
155. Le O, Javadi S, Bhosale PR, Koay EJ, Katz MH, Sun J, Yang W, Tamm EP. CT Features Predictive of Nodal Positivity at Surgery in Pancreatic Cancer Patients Following Neoadjuvant Therapy in the Setting of Dual Energy CT Abdominal Radiology. Abdom Radiol (NY) 46(6):2620-2627, 2021. e-Pub 2021. PMID: 33471129.
156. Bhamidipati D, Colina A, Hwang H, Wang H, Katz M, Fournier K, Serpas V, Thomas J, Sun R, Wolff RA, Raghav K, Overman MJ. Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy. ESMO Open 6(3):100132, 2021. e-Pub 2021. PMID: 33940348.
157. Perri G, Prakash L, Wang H, Bhosale P, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay E, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Radiographic and Serologic Predictors of Pathologic Major Response to Preoperative Therapy for Pancreatic Cancer. Ann Surg 273(4):806-813, 2021. e-Pub 2021. PMID: 31274655.
158. Zhao J, Soto LMS, Wang H, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Wolff RA, Huang Y, Wistuba II, Maitra A, Wang H. Overexpression of CD73 in pancreatic ductal adenocarcinoma is associated with immunosuppressive tumor microenvironment and poor survival. Pancreatology 21(5):942-949, 2021. e-Pub 2021. PMID: 33832821.
159. Parker NH, Basen-Engquist K, Rubin ML, Li Y, Prakash L, Ngo-Huang A, Gorzelitz J, Ikoma N, Lee JE, Katz MHG. Factors influencing exercise following pancreatic tumor resection. Ann Surg Oncol 28(4):2299-2309, 2021. e-Pub 2021. PMID: 32886288.
160. Newhook TE, Soliz JM, Prakash LR, Hancher-Hodges S, Speer BB, Wilks JA, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Impact of Intraoperative Dexamethasone on Surgical and Oncologic Outcomes for Patients with Resected Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol 28(3):1563-1569, 2021. e-Pub 2021. PMID: 32803553.
161. Denbo JW, Kim BJ, Vauthey JN, Tzeng CW, Ma J, Huang SY, Chun YS, Katz MHG, Aloia TA. Overall Body Composition and Sarcopenia Are Associated with Poor Liver Hypertrophy Following Portal Vein Embolization. J Gastrointest Surg 25(2):405-410, 2021. e-Pub 2021. PMID: 31997073.
162. Kothari AN, Trans AT, Caudle AS, Clemens MW, Katz MHG, Woodman SE, Chang GJ. Universal Preoperative SARS-CoV-2 Testing Can Facilitate Safe Surgical Treatment During Local COVID-19 Surges. Br J Surg 108(1):e24-e26, 2021. e-Pub 2021. PMID: 33640925.
163. Allen CJ, Thaker NG, Prakash L, Kruse BC, Feeley TW, Kaplan RS, Huey R, Frank SJ, Aloia TA, Gottumukkala V, Katz MHG. Communicating value: Use of a Novel Framework in the Assessment of an Enhanced Recovery Initiative. Ann Surg 273(1):e7-e9, 2021. e-Pub 2021. PMID: 32568750.
164. Wei, D, Zaid, M, Katz, MH, Prakash, L, Kim, M, Tzeng, CD, Lee, JE, Agrawal, A, Rashid, A, Wang, H, Varadhachary, GR, Wolff, RA, Tamm, EP, Bhosale, PR, Maitra, A, Koay, EJ, Wang, H. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Pancreatology 21(1):200-207, 2021. e-Pub 2021. PMID: 33221151.
165. Hakim S, Coronel E, González GMN, Ge PS, Chari ST, Thosani N, Ramireddy S, Badillo R, DaVee T, Catalano MF, Sealock RJ, Parupudi S, Hernandez LV, Joshi V, Irisawa A, Rana S, Lakhtakia S, Vilmann P, Saftoiu A, Sun S, Giovannini M, Katz MH, Kim MP, Bhutani MS. An international study of interobserver variability of "string sign" of pancreatic cysts among experienced endosonographers. Endoscopic Ultrasound 10(1):39-50, 2021. e-Pub 2021. PMID: 33473044.
166. White MG, Lee A, Vicente D, Hall C, Kim MP, Katz MHG, Lee JE, Ikoma N, Lucci A, Tzeng CD. Measurement of Portal Vein Circulating Tumor Cells is Safe and May Correlate with Outcomes in Resected Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology 28(8):4615-4622, 2021. e-Pub 2021. PMID: 33415562.
167. Ngo-Huang A, Herbert A, Fontillas RC, Parker NH, Asumbrado R, Garg N, Dibaj S, Liu DD, Ng AH, Guo Y, Shin KY, Katz MHG, Bruera E. Frequency of sarcopenia, sarcopenic obesity, and changes in physical function in surgical oncology patients referred for prehabilitation. Integr Cancer Ther 20:15347354211000118, 2021. e-Pub 2021. PMID: 33829906.
168. Parker NH, Gorzelitz J, Ngo-Huang A, Caan BJ, Prakash L, Garg N, Petzel MQB, Schadler K, Basen-Engquist K, Katz MHG. The role of home-based exercise in maintaining skeletal muscle during preoperative pancreatic cancer treatment. Integr Cancer Ther 20:1534735420986615, 2021. e-Pub 2021. PMID: 33870744.
169. Oshi M, Tokumar Y, Patel A, Yan L, Matsuyama R, Endo I, Katz MHG, Takabe K. A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer. Cancers (Basel) 12(12):E3635, 2020. e-Pub 2020. PMID: 33291601.
170. Zaid M, Widmann L, Dai A, Sun K, Zhang J, Zhao J, Hurd M, Varadhachary GR, Wolff RA, Maitra A, Katz MHG, Herman JM, Wang H, Knopp MV, Williams TM, Bhosale P, Tamm EP, Koay EJ. Predictive Modeling for Voxel-Based Quantification of Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma (PDAC): A Multi-Institutional Study. Cancers (Basel) 12(12):E3656, 2020. e-Pub 2020. PMID: 33291471.
171. Wei D, Zaid, MM, Katz MH, Prakash LR, Kim M, Tzeng CD, Lee JE, Agrawal A, Rashid A, Wang H, Varadhachary G, Wolff R, Tamm EP, Bhosale PR, Maitra A, Koay EJ, Wang E. Clinicopathological correlation of radiologic measurement of post-therapy tumor size and tumor volume for pancreatic ductal adenocarcinoma. Pancreatology, 2020. e-Pub 2020.
172. Colina A, Hwang H, Wang H, Katz MHG, Sun R, Lee JE, Thomas J, Tzeng CW, Wolff RA, Raghav K, Overman MJ. Natural History and Prognostic Factors for Localized Small Bowel Adenocarcinoma. ESMO Open 5(6):e000960, 2020. e-Pub 2020. PMID: 33188051.
173. Oshi M, Newman S, Tokumaru Y, Yan L, Matsuyama R, Endo I, Katz MHG, Takabe K. High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection. Cancers (Basel) 12(10):2871, 2020. e-Pub 2020. PMID: 33036243.
174. Perri G, Prakash L, Qiao W, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay EJ, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Response to and survival after first-line FOLFIRINOX or gemcitabine/nab-paclitaxel for localized pancreatic ductal adenocarcinoma. JAMA Surg 155(9):832-839, 2020. e-Pub 2020. PMID: 32667641.
175. Kim BJ, Lillemoe HA, Newhook TE, Dewhurst WL, Arvide EM, Katz MHG, Aloia TA, Vauthey JN, Lee JE, Tzeng CD. Educating Surgical Oncology Providers on Perioperative Opioid Use: A Departmental Survey One Year After Intervention. J Surg Oncol 122(3):547-554, 2020. e-Pub 2020. PMID: 32447769.
176. Tzeng CW, Tran Cao H, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Zeung EEZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JN. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Journal of Surgical Oncology 34:182-185, 2020. e-Pub 2020. PMID: 32891326.
177. Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. e-Pub 2020. PMID: 32675511.
178. Pieterman CRC, Sadowski SM, Maxwell JE, Katz MHG, Lines KE, Heaphy CM, Tirosh A, Blau JE, Perrier ND, Lewis MA, Metzcar JP, Halperin DM, Thakker RV, Valk GD. MEN1-related PanNETs: identifying unmet clinical needs and future directives. Endocr Relat Cancer 27(8):T9-T25, 2020. e-Pub 2020. PMID: 32069215.
179. Ikoma N, Kim MP, Zeng CDT, Tran Cao HS, Lee JE, Katz MH. External Retraction Techniques for Robotic Pancreatoduodenectomy. Journal of the American College of Surgeons, 2020. e-Pub 2020. PMID: 32805403.
180. Takahashi H, Katsuta E, Yan L, Tokumaru Y, Katz MHG, Takabe K. Transcriptomic Profile of Lymphovascular Invasion, A Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis. Cancers (Basel) 12(8):E2033, 2020. e-Pub 2020. PMID: 32722116.
181. Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy. Ann Surg 272(1):163-169, 2020. e-Pub 2020. PMID: 30499795.
182. Keung EZ, Asare EA, Chiang YJ, Prakash LR, Rajkot N, Torres KE, Hunt KK, Feig BW, Cormier JN, Roland CL, Katz MHG, Lee JE, Tzeng CD. Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg 220(1):140-146, 2020. e-Pub 2020. PMID: 31843190.
183. Lillemoe HA, Newhook TE, Aloia TA, Grubbs EG, Chang GJ, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Perceptions of Opioid Use and Prescribing Habits in Oncologic Surgery: A Survey of the Society of Surgical Oncology Membership. Journal of Surgical Oncology, 2020. e-Pub 2020. PMID: 32632993.
184. Perri G, Prakash L, Qiao W, Varadhachary GR, Wolff R, Fogelman D, Overman M, Pant S, Javle M, Koay EJ, Herman J, Kim M, Ikoma N, Tzeng CW, Lee JE, Katz MHG. Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma. Ann Surg 271(6):996-1002, 2020. e-Pub 2020. PMID: 31895709.
185. Zhao B, Blair SL, Katz MHG, Lowy AM, Kelly KJ. Adherence with operative standards in the treatment of gastric cancer in the United States. Gastric Cancer 23(3):550-560, 2020. e-Pub 2020. PMID: 31745679.
186. Capello M, Fahrmann JF, Rios Perez MV, Vykoukal JV, Irajizad E, Tripathi SC, Roife D, Bantis LE, Kang Y, Kundnani DL, Xu H, Prakash LR, Long JP, Katayama H, Fleury A, Ferri-Borgogno S, Baluya DL, Dennison JB, Aguilar Bonavides C, Casabar JP, Celiktas M, Do K, Fiehn O, Maitra A, Wang H, Feng Z, Chiao PJ, Katz MH, Fleming JB, Hanash SM. CES2 expression is predictive of response to irinotecan and is associated with type 2 diabetes. JCO Precision Oncology 4:426-436, 2020. e-Pub 2020.
187. Liu Y, Gu Y, Ng S, Deng Z, Lyon CJ, Koay EJ, Ning B, Katz MH, Chiao PJ, Fan J, Han H, Von Hoff D, Hu TY. Circulating levels of hydroxylated bradykinin function as an indicator of tissue HIF-1α expression. Science Bulletin, 2020. e-Pub 2020.
188. Perri G, Prakash L, Malleo G, Caravati A, Varadhachary GR, Fogelman D, Pant S, Koay EJ, Herman J, Maggino L, Milella M, Kim M, Ikoma N, Tzeng CW, Salvia R, Lee JE, Bassi C, Katz MHG. The sequential radiographic effects of preoperative chemotherapy and (chemo)radiation on tumor anatomy in patients with lcoalized pancreatic cancer. Annals of Surgical Oncology, 2020. e-Pub 2020. PMID: 32266574.
189. Newhook TE, Vreeland TJ, Dewhurst WL, Arvide EM, Bruno ML, Robinson KA, Rajkot N, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Opioid-Prescribing Practices After Oncologic Surgery: Opportunities for Improvement and a Call to Action. Ann Surg 271(2):e9-e10, 2020. e-Pub 2020. PMID: 31478982.
190. Prakash LR, Wang H, Zhao J, Nogueras-Gonzalez GM, Cloyd JM, Tzeng CD, Kim MP, Lee JE, Katz MHG. Significance of Cancer Cells at the Vein Edge in Patients with Pancreatic Adenocarcinoma Following Pancreatectomy with Vein Resection. J Gastrointest Surg 24(2):368-379, 2020. e-Pub 2020. PMID: 30820801.
191. Newhook TE, Vega EA, Vreeland TJ, Prakash L, Dewhurst WL, Bruno ML, Kim MP, Ikoma N, Vauthey JN, Katz MH, Lee JE, Tzeng CD. Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge. Surgery 167(2):442-447, 2020. e-Pub 2020. PMID: 31727324.
192. Bhutani MS, Klapman JB, Tuli R, El-Haddad G, Hoffe S, Wong FCL, Chasen B, Fogelman DR, Lo SK, Nissen NN, Hendifar AE, Varadhachary G, Katz MHG, Erwin WD, Koay EJ, Tamm EP, Singh BS, Mehta R, Wolff RA, Soman A, Cazacu IM, Herman JM. An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advanced pancreatic cancer (OncoPaC-1): Technical details and study protocol. Endosc Ultrasound 9(1):24-30, 2020. e-Pub 2020. PMID: 31670288.
193. Cazacu IM, Chavez AAL, Mendoza TR, Qiao W, Singh BS, Bokhari RH, Saftoiu A, Lee JH, Weston B, Stroehlein JR, Kim MP, Katz MHG, Maitra A, McAllister F, Bhutani MS. Quality of life impact of EUS in patients at risk for developing pancreatic cancer. Endoscopic Ultrasound, 2020. e-Pub 2020.
194. Ngo-Huang A, Parker NH, Bruera E, Lee RE, Simpson R, O'Connor DP, Petzel MQB, Fontillas RC, Schadler K, Xiao L, Wang X, Fogelman D, Sahai SK, Lee JE, Basen-Engquist K, Katz MHG. Home-Based Exercise Prehabilitation During Preoperative Treatment for Pancreatic Cancer Is Associated With Improvement in Physical Function and Quality of Life. Integrative Cancer Therapies, 2019. e-Pub 2019. PMID: 31858837.
195. Wang M, Estrella JS, Katz MH, Kim M, Rashid A, Lee JE, Maitra A, Wistuba II, Wolff RA, Varadhachary GR, Wang H. Expression of Epithelial-Mesenchymal Transition Markers in Treated Pancreatic Ductal Adenocarcinoma. Pancreas 48(10):1367-1372, 2019. e-Pub 2019. PMID: 31688603.
196. Parker NH, Lee RE, O'Connor DP, Ngo-Huang A, Petzel MQB, Schadler K, Wang X, Xiao L, Fogelman D, Simpson R, Fleming JB, Lee JE, Tzeng CWD, Sahai SK, Basen-Engquist K, Katz MHG. Supports and barriers to home-based physical activity during preoperative treatment of pancreatic cancer: a mixed-methods study. Journal of physical activity and health, 2019. e-Pub 2019. PMID: 31592772.
197. Florez Bedoya CA, Cardoso ACF, Parker N, Ngo-Huang A, Petzel MQ, Kim MP, Fogelman D, Romero SG, Wang H, Park M, Katz MHG, Schadler KL. Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients. Scientific Reports 9(1):13966, 2019. e-Pub 2019. PMID: 31562341.
198. Sonoda K, Samdani RT, Ikoma N, Kaya DM, Blum-Murphy M, Ajani JA, Badgwell BD, Katz MH, Rashid A, Estrella JS. Gastric cancer in the remnant stomach after pancreaticoduodenectomy: A case series. Journal of Surgical Oncology 120(7):1137-1141, 2019. e-Pub 2019. PMID: 31498442.
199. Riquelme E, Zhang Y, Zhang L, Montiel M, Zoltan M, Dong W, Quesada P, Sahin I, Chandra V, San Lucas A, Scheet P, Xu H, Hanash SM, Feng L, Burks JK, Do KA, Peterson CB, Nejman D, Tzeng CD, Kim MP, Sears CL, Ajami N, Petrosino J, Wood LD, Maitra A, Straussman R, Katz M, White JR, Jenq R, Wargo J, McAllister F. Tumor Microbiome Diversity and Composition Determine Pancreatic Cancer outcomes. Cell 178(4):795-806, 2019. e-Pub 2019. PMID: 31398337.
200. Khorana AA, McKernin SE, Berlin J, Hong TS, Maitra A, Moravek C, Mumber M, Schulick R, Zeh HJ, Katz MHG. Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology 37(23):2082-2088, 2019. e-Pub 2019. PMID: 31180816.
201. Koay EJ, Katz MHG, Wang H, Wang X, Prakash L, Javle M, Shroff R, Fogelman D, Avila S, Zaid M, Elganainy D, Lee Y, Crane C, Krishnan S, Das P, Fleming JB, Lee JE, Tamm EP, Bhosale P, Lee JH, Weston B, Maitra A, Wolff RA, Varadhachary GR, Koay, equally KP. Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer. JCO Precision Oncology, 2019. e-Pub 2019. PMID: 32914036.
202. Vreeland TJ, McAllister F, Javadi S, Prakash LR, Fogelman DR, Ho L, Varadhachary G, Aloia TA, Vauthey JN, Lee JE, Kim MP, Katz MHG, Tzeng CD. Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX. Pancreas 48(6):837-843, 2019. e-Pub 2019. PMID: 31210666.
203. Khorana AA, McKernin SE, Katz MHG. Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update Summary. Journal of Oncology Practice 15(8):454-457, 2019. e-Pub 2019. PMID: 31306038.
204. Vicente D, Lee AJ, Hall CS, Lucci A, Lee JE, Kim MP, Katz MHG, Hurd MW, Maitra A, Rhim AD, Tzeng CW. Circulating Tumor Cells and Transforming Growth Factor Beta in Resected Pancreatic Adenocarcinoma. Journal of Surgical Research 243:90-99, 2019. e-Pub 2019. PMID: 31170555.
205. Newhook TE, Dewhurst WL, Vreeland TJ, Wang X, Soliz J, Speer BB, Hancher-Hodges S, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD. Inpatient Opioid Use After Pancreatectomy: Opportunities for Reducing Initial Opioid Exposure in Cancer Surgery Patients. Annals of Surgical Oncology, 2019. e-Pub 2019. PMID: 31243665.
206. Janssen QP, Buettner S, Suker M, Beumer BR, Addeo P, Bachellier P, Bahary N, Bekaii-Saab T, Bali MA, Besselink MG, Boone BA, Chau I, Clarke S, Dillhoff M, El-Rayes BF, Frakes JM, Grose D, Hosein PJ, Jamieson NB, Javed AA, Khan K, Kim KP, Kim SC, Kim SS, Ko AH, Lacy J, Margonis GA, McCarter MD, McKay CJ, Mellon EA, Moorcraft SY, Okada KI, Paniccia A, Parikh PJ, Peters NA, Rabl H, Samra J, Tinchon C, van Tienhoven G, van Veldhuisen E, Wang-Gillam A, Weiss MJ, Wilmink JW, Yamaue H, Homs MYV, van Eijck CHJ, Katz MHG, Koerkamp BG. Neoadjuvant FOLFIRINOX in patients with borderline resectable pancreatic cancer: a systematic review and patient-level meta-analysis. Journal of the National Cancer Institute, 2019. e-Pub 2019. PMID: 31086963.
207. Ngo-Huang A, Holmes HM, des Bordes JKA, Parker NH, Fogelman D, Petzel MQB, Song J, Bruera E, Katz MHG. Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma. Cancer Medicine 8(6):2867-2876, 2019. e-Pub 2019. PMID: 31033241.
208. Bhutani MS, Cazacu IM, Luzuriaga Chavez AA, Singh BS, Wong FCL, Erwin WD, Tamm EP, Mathew GG, Le DB, Koay EJ, Taniguchi CM, Minsky BD, Pant S, Tzeng CD, Koong AC, Varadhachary GR, Katz MHG, Wolff RA, Fogelman DR, Herman JM. Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience. VideoGIE 4(5):223-225, 2019. e-Pub 2019. PMID: 31065616.
209. Shroff RT, Kennedy EB, Bachini M, Bekaii-Saab T, Crane C, Edeline J, El-Khoueiry A, Feng M, Katz MHG, Primrose J, Soares HP, Valle J, Maithel SK. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. Journal of Clinical Oncology 37(12):1015-1027, 2019. e-Pub 2019. PMID: 30856044.
210. Cloyd JM, Chen HC, Wang X, Tzeng CD, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG. Chemotherapy vs Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis. Pancreas 48(2):216-222, 2019. e-Pub 2019. PMID: 30629022.
211. Lee AJ, Simoneau E, Chiang YJ, Lee JE, Kim MP, Aloia TA, Vauthey JN, Katz MH, Tzeng CD. Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing. HPB, 2019. e-Pub 2019. PMID: 30799277.
212. Wang EM, Akasaka H, Zhao J, Varadhachary GR, Lee JE, Maitra A, Fleming JB, Hung MC, Wang H, Katz MHG. Expression and Clinical Significance of Protein Kinase RNA-Like Endoplasmic Reticulum Kinase and Phosphorylated Eukaryotic Initiation Factor 2α in Pancreatic Ductal Adenocarcinoma. Pancreas 48(3):323-328. e-Pub 2019.
213. Blando J, Sharma A, Higa MG, Zhao H, Vence L, Yadav SS, Kim J, Sepulveda AM, Sharp M, Maitra A, Wargo J, Tetzlaff M, Broaddus R, Katz MHG, Varadhachary GR, Overman M, Wang H, Tee C, Bernatchez C, Iacobuzio-Donahue C, Basu S, Allison JP, Sharma P. Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America 116(5):1692-1697, 2019. e-Pub 2019. PMID: 30635425.
214. Capello M, Vykoukal JV, Katayama H, Bantis LE, Wang H, Kundnani DL, Aguilar-Bonavides C, Aguilar M, Triphthi SC, Dhillon DS, Momin AA, Peters H, Katz MH, Brand R, Firpo MA, Mulvihill SJ, Molldrem JJ, Feng Z, Taguchi A, Maitra A, Hanash SM. Exosomes are enriched in B cell immune response targets in pancreatic adenocarcinoma and exert a decoy function against complement-mediated cytotoxicity. Nature Communications 10(1):254, 2019. e-Pub 2019. PMID: 30651550.
215. Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CD. Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma. Annals of Surgical Oncology, 2018. e-Pub 2018. PMID: 30539487.
216. Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Zeng CD. Contemporary Analysis of Complications Associated with Biliary Stents During Neoadjuvant Therapy for Pancreatic Adenocarcinoma. HPB 21(6):662-668, 2018. e-Pub 2018. PMID: 30522947.
217. Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CW. Perioperative Blood Transfusions for Vein Resection During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Identification of Clinical Targets for Optimization. HPB 21(7):841-848. e-Pub 2018.
218. Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet P, Taniguchi CM, Tzeng CW, Katz M, Singhi A, Maitra A, Alvarez H. Single Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. Clin Cancer Res 25(7):2194-2205, 2018. e-Pub 2018. PMID: 30385653.
219. Parker N, Ngo-Huang A, Lee RE, O'Connor DP, Basen-Engquist K, Petzel MQB, Wang X, Xiao L, Fogelman DR, Scbadler KL, Simpson RJ, Fleming JB, Lee JE, Varadhachary GR, Sahai SK, Katz MHG. Physical activity and exercise during preoperative pancreatic cancer treatment. Supportive Care in Cancer 27(6):2275-2284, 2018. e-Pub 2018. PMID: 30334105.
220. Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG. The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. American Journal of Surgery 218(1):145-150, 2018. e-Pub 2018. PMID: 30224070.
221. Gulhati P, Prakash L, Katz MHG, Wang X, Javle M, Shroff R, Fogelman D, Lee JE, Tzeng CW, Lee JH, Weston B, Tamm E, Bhosale P, Koay EJ, Maitra A, Wang H, Wolff RA, Varadhachary GR. First-Line Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology 26(2):619-627, 2018. e-Pub 2018. PMID: 30324485.
222. Bannon S, Montiel M, Goldstein J, Dong W, Mork M, Borras E, Varadhachary G, Maitra A, Katz M, Feng L, Futteral A, Fogelman D, Vilar E, Hasanov M, McAllister F. High prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer. Cancer Prevention Research 11(11):679-686, 2018. e-Pub 2018. PMID: 30274973.
223. Bernard V, Kim D, San Lucas FA, Castillo J, Allenson K, Mulu F, Stephens B, Huang J, Semaan A, Guerrero P, Kamyabi N, Zhao J, Hurd M, Koay E, Taniguchi C, Javle M, Wolff R, Katz MHG, Varadhachary G, Maitra A, Alvarez H. Circulating Nucleic Acids Associate with Outcomes of Patients with Pancreatic Cancer. Gastroenterology 156(1):108-118, 2018. e-Pub 2018. PMID: 30240661.
224. Lee Y, Cristini V, Lowengrub JS, Kang Y, San Lucas FA, Hobbs BP, Ye R, Eganainy D, Almahariq M, Amer AM, Yu S, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss K, Chauhan A, Zaid MM, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MHG, Wang H, Bhosale P, Tamm EP, Fleming JB. A visually apparent and quantifiable CT imaging feature identifies biophysical subtypes of pancreatic ductal adenocarcinoma. Clinical Cancer Research 24(23):5883-5894, 2018. e-Pub 2018. PMID: 30082477.
225. Denbo JW, Bruno M, Dewhurst W, Kim MP, Tzeng CW, Aloia TA, Soliz J, Speer BB, Lee JE, Katz MHG. Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy. Surgery 164(3):424-431, 2018. e-Pub 2018. PMID: 29807648.
226. Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CW. Vein Resection during Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Patency Rates and Outcomes Associated with Thrombosis. Journal of Surgical Oncology 117(8):1648-1654, 2018. e-Pub 2018. PMID: 29723419.
227. Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CD, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari A. Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases. Annals of Surgical Oncology 25(6):1709-1715, 2018. e-Pub 2018. PMID: 29626307.
228. Cloyd JM, Nogueras-González GM, Prakash LR, Petzel MQB, Parker NH, Ngo-Huang AT, Fogelman D, Denbo JW, Garg N, Kim MP, Lee JE, Tzeng CD, Fleming JB, Katz MHG. Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy. Journal of Gastrointestinal Surgery 22(4):703-712, 2018. e-Pub 2018. PMID: 29230694.
229. Ivanics T, Bergquist JR, Liu G, Kim MP, Kang Y, Katz MH, Perez MVR, Thomas RM, Fleming JB, Truty MJ. Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant type. Laboratory Investigation 98(7):947-956, 2018. e-Pub 2018. PMID: 29520054.
230. Wang YN, Lee HH, Chou CK, Chen CT, Yang WH, Yao J, Wei Y, Lim SO, Ye Y, Hsu J, Tsou PH, Ko HW, Liu X, Liu CG, Ying H, Wu X, Wang H, Li D, Fogelman D, Katz MH, Javle M, Maitra A, Hung MC. Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer. Cancer Cell 33(4):752-769, 2018. e-Pub 2018. PMID: 29606349.
231. Wolff RA, Wang-Gillam A, Alvarez H, Tiriac H, Engle D, Hou S, Groff AF, San Lucas A, Bernard V, Allenson K, Castillo J, Kim D, Mulu F, Huang J, Stephens B, Wistuba II, Katz M, Varadhachary G, Park Y, Hicks J, Chinnaiyan A, Scampavia L, Spicer T, Gerhardinger C, Maitra A, Tuveson D, Rinn J, Lizee G, Yee C, Levine AJ. Dynamic changes during the treatment of pancreatic cancer. Oncotarget 9(19):14764-14790, 2018. e-Pub 2018. PMID: 29599906.
232. Hui L, Rashid A, Foo WC, Katz MH, Chatterjee D, Wang H, Fleming JB, Tamm EP, Wang H. Significance of T1a and T1b Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas. American Journal of Clinical Pathology 42(5):578-586, 2018. e-Pub 2018. PMID: 29462092.
233. Amer AM, Zaid M, Chaudhury B, Elganainy D, Lee Y, Wilke CT, Cloyd J, Wang H, Maitra A, Wolff RA, Varadhachary G, Overman MJ, Lee JE, Fleming JB, Tzeng CW, Katz MH, Holliday EB, Krishnan S, Minsky BD, Herman JM, Taniguchi CM, Das P, Crane CH, Le O, Bhosale P, Tamm EP, Koay EJ. Imaging-based biomarkers: changes in the tumor interface of pancreatic ductal adenocarcinoma on CT scans indicate response to cytotoxic therapy. Cancer 124(8):1701-1709, 2018. e-Pub 2018. PMID: 29370450.
234. Castillo J, Bernard V, San Lucas FA, Allenson K, Capello M, Kim DU, Gascoyne P, Mulu FC, Stephens BM, Huang J, Wang H, Momin AA, Jacamo RO, Katz M, Wolff R, Javle M, Varadhachary G, Wistuba II, Hanash S, Maitra A, Alvarez H. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients. Annals of Oncology 29(1):223-229, 2018. e-Pub 2018. PMID: 29045505.
235. Fan J, Wei Q, Koay EJ, Liu Y, Ning B, Bernard PW, Zhang N, Han H, Katz MH, Zhao Z, Hu Y. Chemoresistance Transmission via Exosome-Mediated EphA2 Transfer in Pancreatic Cancer. Theranostics 8(21):5986-5994, 2018. e-Pub 2018.
236. Bednarski BK, Slack RS, Katz M, You YN, Papadopolous J, Rodriguez-Bigas MA, Skibber JM, Matin SF, Chang GJ. Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial. Diseases of the Colon and Rectum 61(1):77-83, 2018. e-Pub 2018. PMID: 29215474.
237. Javadi S, Karbasian N, Bhosale P, de Castro Faria S, Le O, Katz MH, Koay EJ, Tamm EP. Imaging findings of recurrent pancreatic cancer following resection. Abdominal Radiology (NY) 43(2):489-496, 2017. e-Pub 2017. PMID: 29198001.
238. Cloyd JM, Katz MHG, Wang H, Cuddy A, You YN. Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma. JAMA Surgery 152(11):1086-1088, 2017. e-Pub 2017. PMID: 28793134.
239. Cloyd JM, Nogueras-Gonzalez GM, Prakash LR, Petzel MQB, Parker NH, Ngo-Huang AT, Fogelman D, Denbo JW, Garg N, Kim MP, Lee JE, Tzeng CWD, Fleming JB, Katz MHG. Anthropometric changes in patients with pancreatic ductal adenocarcinoma undergoing preoperative therapy and pancreatoduodenectomy. Journal of Gastrointestinal Surgery 22(4):703-712, 2017. e-Pub 2017.
240. Isaji S, Mizuno S, Windsor JA, Bassi C, Fernández-Del Castillo C, Hackert T, Hayasaki A, Katz MHG, Kim SW, Kishiwada M, Kitagawa H, Michalski CW, Wolfgang CL. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology 18(1):2-11, 2017. e-Pub 2017. PMID: 29191513.
241. Yamashita S, Overman MJ, Wang H, Zhao J, Okuno M, Goumard C, Tzeng CW, Kim M, Fleming JB, Vauthey JN, Katz MH, Lee JE, Conrad C. Pathologic Response to Preoperative Therapy as a Novel Prognosticator for Ampullary and Duodenal Adenocarcinoma. Ann Surg Oncol 24(13):3954-3963, 2017. e-Pub 2017. PMID: 28980211.
242. Rayamajhi S, Balachandran A, Katz M, Reddy A, Rohren E, Bhosale P. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma. Abdominal Radiology 43(2):505-513, 2017. e-Pub 2017. PMID: 28900703.
243. Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, Mosher CM, Brandis A, Fuks G, Gurbatri C, Gopalakrishnan V, Kim M, Hurd MW, Katz M, Fleming J, Maitra A, Smith DA, Skalak M, Bu J, Michaud M, Trauger SA, Barshack I, Golan T, Sandbank J, Flaherty KT, Mandinova A, Garrett WS, Thayer SP, Ferrone CR, Huttenhower C, Bhatia SN, Gevers D, Wargo JA, Golub TR, Straussman R. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science 357(6356):1156-1160, 2017. e-Pub 2017. PMID: 28912244.
244. Soliz JM, Ifeanyi IC, Katz MH, Wilks J, Cata JP, McHugh T, Fleming JB, Feng L, Rahlfs T, Bruno M, Gottumukkala V. Comparing Postoperative Complications and Inflammatory Markers Using Total Intravenous Anesthesia Versus Volatile Gas Anesthesia for Pancreatic Cancer Surgery. Anesthesia and Pain Medicine 7(4), 2017. e-Pub 2017. PMID: 29344445.
245. Ngo-Huang AT, Parker NH, Wang X, Petzel MQB, Fogelman D, Schadler KL, Bruera E, Fleming JB, Lee JE, Katz MHG. Home based exercise during preoperative therapy for pancreatic cancer. Langenbeck's Archives of Surgery 402(8):1175-1185, 2017. e-Pub 2017. PMID: 28710540.
246. Chéry L, Borregales LD, Fellman B, Urbauer DL, Garg N, Parker N, Katz MHG, Wood CG, Karam JA. The Effects Of Neoadjuvant Axitinib On Anthropometric Parameters In Patients With Locally Advanced Non-Metastatic Renal Cell Carcinoma. Urology 108:114-121, 2017. e-Pub 2017. PMID: 28705573.
247. Cloyd JM, Wang H, Egger ME, Tzeng CD, Prakash LR, Maitra A, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Overman MJ, Koay EJ, Das P, Herman JM, Kim MP, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MHG. Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma. JAMA Surgery 152(11):1048-1056, 2017. e-Pub 2017. PMID: 28700784.
248. Katz MHG, Ou, Fang-Shu, Herman JM, Ahmad S, Wolpin B, Marsh R, Shi Q, Chuong M, Schwarz LH, Frankel W, Collisson E, Koay E, Hubbard J, Leenstra JL, Meyerhardt J, O'Reilly E. Alliance for Clinical Trials in Oncology (Alliance) Trial A021501: Preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas. BMC Cancer 17(1):505, 2017. e-Pub 2017. PMID: 28750659.
249. Tran Cao HS, Zhang Q, Sada YH, Silberfein EJ, Hsu C, Gnd VB, Chai C, Katz MHG, Fisher WE, Massarweh NN. Value of lymph node positivity in treatment planning for early stage pancreatic cancer. Surgery 162(3):557-567, 2017. e-Pub 2017. PMID: 28666686.
250. Chatterjee D, Katz MH, Foo WC, Sundar M, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, Rashid A, Wang H. Prognostic Significance of New AJCC Tumor Stage in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Therapy. American Journal of Surgical Pathology 41(8):1097-1104, 2017. e-Pub 2017. PMID: 28614206.
251. Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, Mohile SG, Mumber M, Schulick R, Shapiro M, Urba S, Zeh HJ, Katz MH. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology 35(20):2324-2328, 2017. e-Pub 2017. PMID: 28398845.
252. Allenson K, Castillo J, San Lucas FA, Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ, Foretova L, Fabianova E, Holcatova I, Janout V, Meric-Bernstam F, Gascoyne P, Wistuba I, Varadhachary G, Brennan P, Hanash S, Li D, Maitra A, Alvarez H. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Annals of Oncology 28(4):741-747, 2017. e-Pub 2017. PMID: 28104621.
253. Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Brennan L, Feng E, Taguchi I, Janout V, Firpo MA, Mulvihill SJ, Katz MH, Hanash SM. Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. Journal of the National Cancer Institute 109(4), 2017. e-Pub 2017. PMID: 28376157.
254. Khorana AA, Mangu PB, Katz MH. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary. Journal of Oncology Practice 13(6):388-391, 2017. e-Pub 2017. PMID: 28406730.
255. Colbert LE, Moningi S, Chadha A, Amer A, Lee Y, Wolff RA, Varadhachary G, Fleming J, Katz M, Das P, Krishnan S, Koay EJ, Park P, Crane CH, Taniguchi CM. Dose escalation with an IMRT technique in 15 to 28 fractions is better tolerated than standard doses of 3DCRT for LAPC. Advances in Radiation Oncology 2(3):403-415, 2017. e-Pub 2017. PMID: 29114609.
256. Chadha AS, Liu G, Chen HC, Das P, Minsky BD, Mahmood U, Delclos ME, Suh Y, Sawakuchi GO, Beddar S, Katz MH, Fleming JB, Javle MM, Varadhachary GR, Wolff RA, Crane CH, Wang X, Thames H, Krishnan S. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?. Int J Radiat Oncol Biol Phys 97(2):323-332, 2017. e-Pub 2017. PMID: 28068240.
257. Liu Q, Stewart J, Wang H, Rashid A, Zhao J, Katz MH, Lee JE, Fleming JB, Maitra A, Wolff RA, Varadhachary GR, Krishnan S, Wang H. Reduced expression of argininosuccinate synthetase 1 has a negative prognostic impact in patients with pancreatic ductal adenocarcinoma. PLoS One 12(2), 2017. e-Pub 2017. PMID: 28187218.
258. Golan T, Sella T, O'Reilly EM, Katz MH, Epelbaum R, Kelsen DP, Borgida A, Maynard H, Kindler H, Friedmen E, Javle M, Gallinger S. Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer. Br J Cancer 116(6):697-702. e-Pub 2017. PMID: 28183138.
259. Liang K, Liu F, Fan J, Sun D, Liu C, Lyon CJ, Bernard DW, Li Y, Yokoi K, Katz MH, Koay EJ, Zhao, Z, Hu Y. Nanoplasmonic quantification of tumour-derived extracellular vesicles in plasma microsamples for diagnosis and treatment monitoring. Nature Biomedical Engineering, 2017. e-Pub 2017. PMID: 28791195.
260. Vega EA, Yamashita S, Chun YS, Kim M, Fleming JB, Katz MH, Tzeng CW, Raghav KP, Vauthey JN, Lee JE, Conrad C. Effective Laparoscopic Management Lymph Node Dissection for Gallbladder Cancer. Ann Surg Oncol 24(7):1852. e-Pub 2017. PMID: 28168387.
261. Cloyd JM, Wang H, Overman M, Zhao J, Denbo J, Prakash L, Kim MP, Shroff R, Javle M, Varadhachary GR, Fogelman D, Wolff RA, Koay EJ, Das P, Maitra A, Aloia TA, Vauthey JN, Fleming JB, Lee JE, Katz MH. Influence of Preoperative Therapy on Short- and Long-Term Outcomes of Patients with Adenocarcinoma of the Ampulla of Vater. Annals of Surgical Oncology 24(7):2031-2039, 2017. e-Pub 2017. PMID: 28124275.
262. Roife D, Kang Y, Wang L, Fang B, Swisher SG, Gershenwald JE, Pretzsch S, Dinney CP, Katz MH, Fleming JB. Generation of patient-derived xenografts from fine needle aspirates or core needle biopsy. Surgery 161(5):124, 2017. e-Pub 2017. PMID: 28081955.
263. Denbo JW, Slack RS, Bruno M, Cloyd JM, Prakash L, Fleming JB, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH. Selective Perioperative Administration of Pasireotide is More Cost-Effective Than Routine Administration for Pancreatic Fistula Prophylaxis. J Gastrointest Surg 21(4):636-646. e-Pub 2017. PMID: 28050766.
264. Nejati R, Goldstein JB, Halperin DM, Wang H, Hejazi N, Rashid A, Katz MH, Lee JE, Fleming JB, Rodriguez-Canales J, Blando J, Wistuba II, Maitra A, Wolff RA, Varadhachary GR, Wang H. Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy. Pancreas 46(9):1180-1187, 2017. e-Pub 2017. PMID: 28902789.
265. Kutlu OC, Lee JE, Katz MH, Tzeng CD, Wolff RA, Varadhachary GR, Vauthey JN, Fleming JB, Conrad C. Open Pancreaticoduodenectomy Case Volume Predicts Outcome of Laparoscopic Approach: A Population-based Analysis. Ann Surg 267(3):552-560. e-Pub 2016. PMID: 28045744.
266. Vega EA, Yamashita S, Shin CY, Kim M, Fleming JB, Katz MH, Raghav KP, Vauthey JN, Lee JE, Conrad C. Laparoscopic Partial Splenectomy for Unknown Primary Cancer: A Stepwise Approach. Annals of Surgical Oncology 24(4):1134. e-Pub 2016. PMID: 27942901.
267. Roland CL, Starker LF, Kang Y, Chatterjee D, Estrella J, Rashid A, Katz MH, Aloia TA, Lee JE, Dasari A, Yao JC, Fleming JB. Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection. Surgery 161(3):753-759, 2016. e-Pub 2016. PMID: 27816207.
268. Cloyd JM, Tran Cao HS, Petzel MQ, Denbo JW, Parker NH, Nogueras-González GM, Liles JS, Kim MP, Lee JE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. Journal of Surgical Oncology 115(2):144-150, 2016. e-Pub 2016. PMID: 27859270.
269. Conrad C, Kutlu OC, Dasari A, Chan JA, Vauthey JN, Adams DB, Kim M, Fleming JB, Katz MH, Lee JE. Prognostic Value of Lymph Node Status and Extent of Lymphadenectomy in Pancreatic Neuroendocrine Tumors Confined To and Extending Beyond the Pancreas. Journal of Gastrointestinal Surgery 20(12):1966-74, 2016. e-Pub 2016. PMID: 27714644.
270. Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. Journal of Gastrointestinal Surgery 21(1):164-174, 2016. e-Pub 2016. PMID: 27778257.
271. Denbo JW, Bruno ML, Cloyd JM, Prakash L, Lee JE, Kim M, Crane CH, Koay EJ, Krishnan S, Das P, Minsky BD, Varadhachary G, Shroff R, Wolff R, Javle M, Overman MJ, Fogelman D, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality. Journal of Gastrointestinal Surgery 20(12):1975-85, 2016. e-Pub 2016. PMID: 27730398.
272. Lee SM, Katz MH, Liu L, Sundar M, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Fleming JB, Rashid A, Wang H. Validation of a Proposed Tumor Regression Grading Scheme for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy as a Prognostic Indicator for Survival. American Journal of Surgical Pathology 40(12):1653-60, 2016. e-Pub 2016. PMID: 27631521.
273. Hoover M, Adamian Y, Brown M, Maawy A, Chang A, Lee J, Gharibi A, Katz MH, Fleming J, Hoffman RM, Bouvet M, Doebler R, Kelber JA. A novel method for RNA extraction from FFPE samples reveals significant differences in biomarker expression between orthotopic and subcutaneous pancreatic cancer patient-derived xenografts. Oncotarget 8(4):5885-5894, 2016. e-Pub 2016. PMID: 27602776.
274. Prakash L, Bhosale P, Cloyd J, Kim M, Parker N, Yao J, Dasari A, Halperin D, Aloia T, Lee JE, Vauthey JN, Fleming JB, Katz MH. Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery 21(1):155-163, 2016. e-Pub 2016. PMID: 27634306.
275. Katz MH, Shi Q, Ahmad SA, Herman JM, Marsh RW, Collisson E, Schwartz L, Frankel W, Martin R, Conway W, Truty M, Kindler H, Lowy AM, Bekaii-Saab T, Philip P, Talamonti M, Cardin D, LoConte N, Shen P, Hoffman JP, Venook AP. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surgery 151(8), 2016. e-Pub 2016. PMID: 27275632.
276. Hanania AN, Le B, Feng Z, Wang H, Tamm E, Katz MH, Maitra A, Koay EJ. Quantitative Imaging to Evaluate Malignant Potential of IPMNs. Oncotarget 7(52):85776-85784, 2016. e-Pub 2016. PMID: 27588410.
277. Chadha AS, Skinner HD, Gunther JR, Munsell MF, Das P, Minsky BD, Delclos ME, Chatterjee D, Wang H, Clemons M, George G, Singh PK, Katz MH, Fleming JB, Javle MM, Wolff RA, Varadhachary GR, Crane CH, Krishnan S. Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer. PLoS One 11(6), 2016. e-Pub 2016.
278. Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, Mohile SG, Mumber M, Schulick R, Shapiro M, Urba S, Zeh HJ, Katz MH. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 34(21):2541-56, 2016. e-Pub 2016. PMID: 27247221.
279. Cloyd JM, Crane CH, Koay EJ, Das P, Krishnan S, Prakash L, Snyder RA, Varadhachary GR, Wolff RA, Javle M, Shroff RT, Fogelman D, Overman M, Wang H, Maitra A, Lee JE, Fleming JB, Katz MH. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Cancer 122(17), 2016. e-Pub 2016. PMID: 27243381.
280. Katz MH, Slack R, Bruno M, McMillan J, Fleming JB, Lee JE, Bednarski B, Papadopoulos J, Matin SF. Outpatient virtual clinical encounters after complex surgery for cancer: a prospective pilot study of "TeleDischarge". J Surg Res 202(1):196-203, 2016. e-Pub 2016.
281. Butler JR, Ahmad SA, Katz MH, Cioffi JL, Zyromski NJ. A systematic review of the role of periadventitial dissection of the superior mesenteric artery in affecting margin status after pancreatoduodenectomy for pancreatic adenocarcinoma. HPB 18(4):305-11, 2016. e-Pub 2016. PMID: 27037198.
282. Fleming JB, Kang Y, Roife D, Lee Y, Lv H, Suzuki R, Ling J, Rios Perez MV, Li X, Dai B, Pratt M, Truty MJ, Chatterjee D, Wang H, Thomas RM, Wang Y, Koay EJ, Chiao PJ, Katz MH. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors. Clin Cancer Res 22(19):4934-46. e-Pub 2016. PMID: 27126993.
283. Wang OH, Azizian N, Guo M, Capello M, Deng D, Zang F, Fry J, Katz MH, Fleming JB, Lee JE, Wolff RA, Hanash S, Wang H, Maitra A. Prognostic and Functional Significance of MAP4K5 in Pancreatic Cancer. PLoS One 29(11):3, 2016. e-Pub 2016. PMID: 27023625.
284. Conrad C, Passot G, Katz MH, Fleming JB, Kim M, Chun YS, Aloia TA, Vauthey JN, Lee JE. Laparoscopic Insulinoma Enucleation from the Retro-Pancreatic Neck: A Stepwise Approach. Annals of Surgical Oncology 23(6):2001. e-Pub 2016. PMID: 26960928.
285. Krishnan S, Chadha AS, Suh Y, Chen HC, Rao A, Das P, Minsky BD, Mahmood U, Delclos ME, Sawakuchi GO, Beddar S, Katz MH, Fleming JB, Javle MM, Varadhachary GR, Wolff RA, Crane CH. Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation. Int J Radiat Oncol Biol Phys 94(4):755-765, 2016. e-Pub 2016. PMID: 26972648.
286. Giovinazzo F, Turri G, Katz MH, Heaton N, Ahmed I. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma. Br J Surg 103(3):179-191, 2016. e-Pub 2016. PMID: 26663252.
287. Parikh AA, Maiga A, Bentrem D, MHrd S, Kooby DA, Maithel SK, Weber SM, Cho CS, Katz M, Martin RC, Scoggins CR, Sutton J, Ahmad SA, Abbott DE, Carr J, Kim HJ, Yakoub D, Idrees K, Merchant N. Adjuvant Therapy in Pancreas Cancer: Does It Influence Patterns of Recurrence?. Journal of the American College of Surgeons 222(4):448-56, 2016. e-Pub 2016. PMID: 26895735.
288. Fischer LK, Katz MH, Lee SM, Liu L, Wang H, Varadhachary GR, Wolff RA, Lee JE, Maitra A, Roland CL, Fleming JB, Estrella J, Rashid A, Wang H. The Number and Ratio of Positive Lymph Nodes Affect Pancreatic Cancer Patient Survival after Neoadjuvant Therapy and Pancreaticoduodenectomy. Histopathology 68(2):210-220, 2016. e-Pub 2016. PMID: 25945396.
289. Day RW, Fleming J, Katz MH, Grubbs E, Bednarski BK, Lee JE, Aloia TA. Rapid assessment of technical competency: the 8-min suture test. Journal of Surgical Research 200(1):46-52, 2016. e-Pub 2016. PMID: 26276369.
290. Labori KJ, Katz MH, Tzeng CW, Bjørnbeth BA, Cvancarova M, Edwin B, Kure EH, Eide TJ, Dueland S, Buanes T, Gladhaug IP. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study. Acta Oncol 55(3):265-277, 2016. e-Pub 2016. PMID: 26213211.
291. Mise Y, Vauthey JN, Zimmitti G, Parker NH, Conrad C, Aloia TA, Lee JE, Fleming JB, Katz MH. Ninety-day Postoperative Mortality Is a Legitimate Measure of Hepatopancreatobiliary Surgical Quality. Ann Surg 262(6):1071-1078, 2015. e-Pub 2015.
292. Yamasaki A, Mise Y, Mise Y, Lee JE, Aloia TA, Katz MH, Chang GJ, Lillemoe KD, Raut CP, Conrad C. Musical preference correlates closely to professional roles and specialties in operating room: A multicenter cross-sectional cohort study with 672 participants. Surgery 159(5):1260-68. e-Pub 2015. PMID: 26706609.
293. Conrad C, Schwarz L, Perrier N, Fleming JB, Katz MH, Aloia TA, Vauthey JN, Lee JE. Spleen and splenic vessel preserving distal pancreatectomy for bifocal PNET in a young patient with MEN1. Surgical Endoscopy 30(10):4619. e-Pub 2015. PMID: 26721691.
294. Roland CL, Katz MH, Tzeng CD, Lin H, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Vauthey JN, Crane CH, Lee JE, Fleming JB. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy. Annals of Surgical Oncology 22(3):1221-1228, 2015. e-Pub 2015. PMID: 26350371.
295. San Lucas FA, Allenson K, Bernard V, Castillo J, Kim DU, Ellis K, Ehli EA, Davies GE, Petersen JL, Li D, Wolff R, Katz M, Varadhachary G, Wistuba I, Maitra A, Alvarez H. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes. Ann Oncol 27(4):635-41. e-Pub 2015.
296. Schwarz L, Fleming J, Katz M, Lee J, Aloia T, Vauthey N, Conrad C. Total Laparoscopic Central Pancreatectomy with Pancreaticogastrostomy for High-Risk Cystic Neoplasm. Annals of Surgical Oncology 23(3):1035. e-Pub 2015. PMID: 26542586.
297. Day RW, Brudvik KW, Vauthey JN, Conrad C, Gottumukkala V, Chun YS, Katz MH, Fleming JB, Lee JE, Aloia TA. Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery. Surgery 159(3):793-801. e-Pub 2015. PMID: 26584854.
298. Prakash L, Lee JE, Yao J, Bhosale P, Balachandran A, Wang H, Fleming JB, Katz MH. Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Surgery 19(11):2011-2018, 2015. e-Pub 2015. PMID: 26282850.
299. Schwarz L, Bruno M, Parker NH, Prakash L, Mise Y, Lee JE, Vauthey JN, Aloia TA, Conrad C, Fleming JB, Katz MH. Active Surveillance for Adverse Events Within 90 Days: The Standard for Reporting Surgical Outcomes After Pancreatectomy. Annals of Surgical Oncology 22(11):3522-3529, 2015. e-Pub 2015. PMID: 25694246.
300. Marcal LP, Fox PS, Evans DB, Fleming JB, Varadhachary GR, Katz MH, Tamm EP. Analysis of free-form radiology dictations for completeness and clarity for pancreatic cancer staging. Abdominal Imaging 40(7):2391-2397, 2015. e-Pub 2015. PMID: 25906341.
301. Liu L, Katz MH, Lee SM, Fischer LK, Prakash L, Parker N, Wang H, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Maitra A, Fleming JB, Estrella J, Rashid A, Wang H. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. American Journal of Surgical Pathology 39(10):1395-1403, 2015. e-Pub 2015. PMID: 26200098.
302. Mise Y, Day RW, Vauthey JN, Brudvik KW, Schwarz L, Prakash L, Parker NH, Katz MH, Conrad C, Lee JE, Fleming JB, Aloia TA. After Pancreatectomy, the "90 Days from Surgery" Definition Is Superior to the "30 Days from Discharge" Definition for Capture of Clinically Relevant Readmissions. J Gastrointest Surg 20(1):77-84. e-Pub 2015. PMID: 26493976.
303. Bektas M, Krishna SG, Ross WA, Weston B, Katz MH, Fleming JB, Lee JH, Bhutani MS. Prevalence of extra-pancreatic cysts in patients with cystic pancreatic lesions detected by endoscopic ultrasound. Endoscopic Ultrasound 4(3):219-224, 2015. e-Pub 2015.
304. Xia M, Overman MJ, Rashid A, Chatterjee D, Wang H, Katz MH, Fleming JB, Lee JE, Varadhachary GR, Wolff RA, Wang H. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma. Human Pathology 46(9):1315-1322, 2015. e-Pub 2015. PMID: 26165226.
305. Yano S, Hiroshima Y, Maawy A, Kishimoto H, Suetsugu A, Miwa S, Toneri M, Yamamoto M, Katz MH, Fleming JB, Urata Y, Tazawa H, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM. Color-coding cancer and stromal cells with genetic reporters in a patient-derived orthotopic xenograft (PDOX) model of pancreatic cancer enhances fluorescence-guided surgery. Cancer Gene Therapy 22(7):344-350, 2015. e-Pub 2015. PMID: 26088297.
306. Chadha AS, Kocak-Uzel E, Das P, Minsky BD, Delclos ME, Mahmood U, Guha S, Ahmad M, Varadhachary G, Javle M, Katz MH, Fleming JB, Wolff RA, Crane CH, Krishnan. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Acta Oncologica 54(7):971-978, 2015. e-Pub 2015.
307. Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia TA, Conrad C, Vauthey JN, Fleming JB, Katz MHG. Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer. Annals of Surgical Oncology 22(7):2416-2423, 2015. e-Pub 2015. PMID: 25519927.
308. Labori KJ, Katz MH, Tzeng CW, Bjornbeth BA, Cvancarova M, Edwin B, Kure EH, Eide TJ, Dueland S, Buanes T, Gladhaug LP. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study. Acta Oncologica 55(3):265-77. e-Pub 2015.
309. Thomas RM, Truty MJ, Kim M, Kang Y, Zhang R, Chatterjee D, Katz MH, Fleming JB. The Canary in the Coal Mine: The Growth of Patient-Derived Tumorgrafts in Mice Predicts Clinical Recurrence after Surgical Resection of Pancreatic Ductal Adenocarcinoma. Annals of Surgical Oncology 22(6):1884-1892, 2015. e-Pub 2015. PMID: 25404477.
310. Capello M, Lee M, Wang H, Babel I, Katz MH, Fleming JB, Maitra A, Wang H, Tian W, Taguchi A, Hanash SM. Carboxylesterase 2 as a Determinant of Response to Irinotecan and Neoadjuvant FOLFIRINOX Therapy in Pancreatic Ductal Adenocarcinoma. J Natl Cancer Inst 107(8), 2015. e-Pub 2015. PMID: 26025324.
311. Roland CL, Yang AD, Katz MH, Chatterjee D, Wang H, Lin H, Vauthey JN, Pisters PW, Varadhachary GR, Wolff RA, Crane CH, Lee JE, Fleming JB. Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer. Annals of Surgical Oncology 22(4):1168-1175, 2015. e-Pub 2015. PMID: 25352267.
312. Kang Y, Zhang R, Suzuki R, Li SQ, Roife D, Truty MJ, Chatterjee D, Thomas RM, Cardwell J, Wang Y, Wang H, Katz MH, Fleming JB. Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype. Lab Invest 95(2):207-222, 2015. e-Pub 2015. PMID: 25485535.
313. Cooper AB, Parmar AD, Riall TS, Hall BL, Katz MH, Aloia TA, Pitt HA. Does the Use of Neoadjuvant Therapy for Pancreatic Adenocarcinoma Increase Postoperative Morbidity and Mortality Rates?. Journal of Gastrointestinal Surgery 19(1):80-86, 2015. e-Pub 2015. PMID: 25091851.
314. Fogelman DR, Holmes H, Mohammed K, Katz MHG, Prado CM, Lieffers J, Garg N, Varadhachary GR, Shroff R, Overman MJ, Garrett C, Wolff RA, Javle M. Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer?. Journal of Cachexia Sarcopenia and Muscle 5(4):307-313, 2014. e-Pub 2014.
315. Hiroshima Y, Maawy A, Zhang Y, Murakami T, Momiyama M, Mori R, Matsuyama R, Katz MH, Fleming JB, Chishima T, Tanaka K, Ichikawa Y, Endo I, Hoffman RM, Bouvet M. Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-CA 19-9-Conjugated Fluorophore. PLoS One 9(12):e114310, 2014. e-Pub 2014. PMID: 25463150.
316. Li X, Truty MJ, Kang Y, Chopin-Laly X, Zhang R, Roife DJ, Chatterjee D, Lin E, Thomas RM, Wang H, Katz MH, Fleming JB. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery. Clinical Cancer Res 20(24):6529-6540, 2014. e-Pub 2014.
317. Koay EJ, Baio FE, Ondari A, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Zhang J, Court L, Bhosale PR, Tamm EP, Qayyum A, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Maitra A, Ferrari M, Varadhachary GR, Fleming JB. Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Phys Biol 11(6), 2014. e-Pub 2014. PMID: 25427073.
318. Hiroshima Y, Maawy AA, Katz MH, Fleming JB, Bouvet M, Endo I, Hoffman RM. Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer. Journal of Surgical Oncology 111(3):311-315, 2014. e-Pub 2014. PMID: 25394368.
319. Kang Y, Ling J, Suzuki R, Roife D, Chopin-Laly X, Truty MJ, Chaterjee D, Wang H, Thomas RM, Katz MH, Chiao PJ, Fleming JB. SMAD4 Regulates Cell Motility through Transcription of N-Cadherin in Human Pancreatic Ductal Epithelium. PLoS One 9(9), 2014. e-Pub 2014. PMID: 25264609.
320. Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey N, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG. Borderline Resectable Adrenal Cortical Carcinoma: A Potential Role for Preoperative Chemotherapy. World Journal of Surgery 38(6):1318-1327, 2014. e-Pub 2014. PMID: 24615603.
321. Tzeng CW, Balachandran A, Ahmad M, Lee JE, Krishnan S, Wang H, Crane CH, Wolff RA, Varadhachary GR, Pisters PW, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford) 16(5):430-438, 2014. e-Pub 2014.
322. Guo R, Overman M, Chatterjee D, Rashid A, Shroff S, Wang H, Katz MH, Fleming JB, Varadhachary GR, Abbruzzese JL, Wang H. Aberrant expression of p53, p21, cyclin D1, and Bcl2 and their clinicopathological correlation in ampullary adenocarcinoma. Human Pathology 45(5):1015-1023, 2014. e-Pub 2014. PMID: 24746206.
323. Koay EJ, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Bhosale PR, Tamm EP, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Varadhachary GR, Ferrari M, Fleming JB. Transport properties of pancreatic cancer describe gemcitabine delivery and response. Journal of Clinical Investigation 124(4):1525-1536, 2014. e-Pub 2014. PMID: 24614108.
324. Tzeng CW, Katz MH, Lee JE, Fleming JB, Pisters PW, Vauthey JN, Aloia TA. Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13 771 NSQIP patients. HPB (Oxford) 16(4):373-383, 2014. e-Pub 2014. PMID: 23869628.
325. Shroff S, Rashid A, Wang H, Katz MH, Abbruzzese JL, Fleming JB, Wang H. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. Human Pathology 45(3):456-463, 2014. e-Pub 2014.
326. Cooper AB, Holmes HM, des Bordes JKA, Fogelman D, Parker NH, Lee JE, Aloia TA, Vauthey JN, Fleming JB, Katz MH. The role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. Journal of the American College of Surgeons 219(1):111-120, 2014. e-Pub 2014.
327. Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Radiographic Tumor-Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer. Journal of Gastrointestinal Surgery 18(2):269-278, 2014. e-Pub 2014.
328. Estrella JS, Li L, Rashid A, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Solid pseudopapillary neoplasm of the pancreas: clinicopathologic and survival analyses of 64 cases from a single institution. American Journal of Surgical Pathology 38(2):147-57, 2014. e-Pub 2014.
329. Hiroshima Y, Zhao M, Maawy A, Zhang Y, Katz MH, Fleming JB, Uehara F, Miwa S, Yano S, Momiyama M, Suetsugu A, Chishima T, Tanaka K, Bouvet M, Endo I, Hoffman RM. Efficacy of Salmonella typhimurium A1-R Versus Chemotherapy on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX). Journal of Cellular Biochemistry 115:1254-1261. e-Pub 2014.
330. Tzeng CW, Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival. Journal of Gastrointestinal Surgery 18(1):16-24, 2014. e-Pub 2014. PMID: 24241967.
331. Tzeng CW, Katz MH, Fleming JB, Lee JE, Pisters PW, Holmes HM, Varadhachary GR, Wolff RA, Abbruzzese JL, Vauthey JN, Aloia TA. Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification. Journal of Gastrointestinal Surgery 18(1):146-155, 2014. e-Pub 2014.
332. Zenali M, Overman MJ, Rashid A, Broaddus RB, Wang H, Katz MH, Fleming JB, Abbruzzese JL, Wang H. Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinoma. Human Pathology 44(12):2792-2798, 2013. e-Pub 2013.
333. Lee S, Reha JL, Tzeng CWD, Massarweh NN, Chang GJ, Hetz SP, Fleming JB, Lee JE, Katz MH. Race does not impact pancreatic cancer treatment and survival in an equal access federal healthcare system. Annals of Surgical Oncology 20(13):4073-4079, 2013. e-Pub 2013.
334. Abbott DE, Tzeng CW, Merkow RP, Cantor SB, Chang GJ, Katz MH, Bentrem DJ, Bilimoria KY, Crane CH, Varadhachary GR, Abbruzzese JL, Wolff RA, Lee JE, Evans DB, Fleming JB. The Cost-Effectiveness of Neoadjuvant Chemoradiation is Superior to a Surgery-First Approach in the Treatment of Pancreatic Head Adenocarcinoma. Ann Surg Oncol 20(3):S500-5008, 2013. e-Pub 2013. PMID: 23397153.
335. Chatterjee D, Katz MH, Rashid A, Estrella JS, Wang H, Varadhachary VR, Wolff RA, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB, Wang H. Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma. Histopathology 63(6):841-851, 2013. e-Pub 2013.
336. Shroff S, Overman MJ, Rashid A, Shroff RT, Wang H, Chatterjee D, Katz MH, Lee JE, Wolff RA, Abbruzzese JL, Fleming JB, Wang H. The Expression of PTEN Is Associated With Improved Prognosis in Patients With Ampullary Adenocarcinoma After Pancreaticoduodenectomy. Archives of Pathology and Laboratory Medicine 137(11):1619-1626, 2013. e-Pub 2013.
337. Jiang ZQ, Varadhachary G, Wang X, Kopetz S, Lee JE, Wang H, Shroff R, Katz M, Wolff RA, Fleming J, Overman MJ. A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine- based chemotherapy. Annals of Oncology 24(9):2349-2353, 2013. e-Pub 2013.
338. Katz MH, Marsh R, Herman JM, Shi Q, Collison E, Venook AP, Kindler HL, Alberts SR, Philip P, Lowy AM, Pisters PW, Posner MC, Berlin JD, Ahmad SA. Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design. Ann Surg Oncol 20(8):2787-95, 2013. e-Pub 2013. PMID: 23435609.
339. Tzeng CW, Abbott DE, Cantor SB, Fleming JB, Lee JE, Pisters PW, Varadhachary GR, Abbruzzese JL, Wolff RA, Ahmad SA, Katz MH. Frequency and Intensity of Postoperative Surveillance After Curative Treatment of Pancreatic Cancer: A Cost-Effectiveness Analysis. Ann Surg Oncol 20(7):2197-203, 2013. e-Pub 2013. PMID: 23408126.
340. Landry CS, Lin HY, Phan A, Charnsangavej C, Abdalla EK, Aloia T, Nicolas Vauthey J, Katz MH, Yao JC, Fleming JB. Resection of At-Risk Mesenteric Lymph Nodes Is Associated with Improved Survival in Patients with Small Bowel Neuroendocrine Tumors. World J Surg 37(7):1695-700, 2013. e-Pub 2013. PMID: 23657749.
341. Foo WC, Rashid A, Wang H, Katz MH, Lee JE, Pisters PW, Wolff RA, Abbruzzese JL, Fleming JB, Wang H. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma. Hum Pathol 44(6):1024-30, 2013. e-Pub 2013. PMID: 23260327.
342. Badgwell B, Stanley J, Chang GJ, Katz MH, Lin HY, Ning J, Klimberg SV, Cormier JN. Comprehensive geriatric assessment of risk factors associated with adverse outcomes and resource utilization in cancer patients undergoing abdominal surgery. J Surg Oncol 108(3):182-186. e-Pub 2013. PMID: 23804149.
343. Li L, Othman M, Rashid A, Wang H, Li Z, Katz MH, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB, Wang H. Solid pseudopapillary neoplasm of the pancreas with prominent atypical multinucleated giant tumour cells. Histopathology 62(3):465-71, 2013. e-Pub 2013. PMID: 23134473.
344. Saftoiu A, Bhutani MS, Vilmann P, Surlin V, Uthamanthil RK, Lee JH, Bektas M, Singh H, lonut D, Gheonea, Pactrascu S, Gupta V, Katz MH, Fleming JB. Feasibility study of EUS-NOTES as a novel approach for pancreatic cancer staging and therapy: an international collaborative study. Hepatogastroenterology 60(121):180-6, 2013. e-Pub 2013. PMID: 22776721.
345. Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PW, Lee JE, Rice DC, Hofstetter WL, Wolff RA, Varadhachary GR, Wang H, Katz MH. Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg 16(9):1696-1704, 2012. e-Pub 2012. PMID: 22644446.
346. Balachandran A, Tamm EP, Bhosale PR, Katz MH, Fleming JB, Yao JC, Charnsangavej C. Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumors. American Journal of Roentgenology 199(3):602-608. e-Pub 2012.
347. Petzel MQ, Parker NH, Valentine AD, Simard S, Nogueras-Gonzalez GM, Lee JE, Pisters PW, Vauthey JN, Fleming JB, Katz MH. Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumors. Annals of Surgical Oncology 19(13):4078-4084, 2012. e-Pub 2012. PMID: 22875648.
348. Weng S, Wang H, Chen W, Katz MH, Chaterjee D, Lee JE, Pisters PW, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 21(8):1336-1343, 2012. e-Pub 2012. PMID: 22665577.
349. Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5,651 NSQIP patients. HPB (Oxford) 14(8):506-513, 2012. e-Pub 2012.
350. Katz MH, Lee JE, Pisters PW, Skoracki R, Tamm E, Fleming JB. Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniques. J Am Coll Surg 215(2):e11-18, 2012. e-Pub 2012.
351. Truty MJ, Thomas RM, Katz MH, Vauthey JN, Crane C, Varadhachary GR, Wolff RA, Abbruzzese JL, Lee JE, Fleming JB. Multimodality Therapy Offers a Chance for Cure in Patients with Pancreatic Adenocarcinoma Deemed Unresectable at First Operative Exploration. J Am Coll Surg 215(1):41-51, 2012. e-Pub 2012.
352. Roland CL, Katz MH, Gonzalez GM, Pisters PW, Vauthey JN, Wolff RA, Crane CH, Lee JE, Fleming JB. A high positive lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinoma. Journal of Gastrointestinal Surgery 16(11):2056-2063. e-Pub 2012.
353. Suetsugu A, Katz M, Fleming J, Truty M, Thomas R, Saji S, Moriwaki H, Bouvet M, Hoffman RM. Non-invasive Fluorescent-protein Imaging of Orthotopic Pancreatic-cancer-patient Tumorgraft Progression in Nude Mice. Anticancer Research 32(8):3063-3067, 2012. e-Pub 2012.
354. Tzeng CW, Fleming JB, Lee JE, Wang X, Pisters PW, Vauthey JN, Varadhachary G, Wolff RA, Katz MH. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford) 14(6):365-72. e-Pub 2012.
355. Katz MH, Fleming JB, Bhosale P, Varadhachary G, Lee JE, Wolff R, Wang H, Abbruzzese J, Pisters PW, Vauthey JN, Charnsangavej C, Tamm E, Crane CH, Balachandran A. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer 118(23):5479-5756. e-Pub 2012.
356. Berri RN, Sahai SK, Durand JB, Lin HY, Folloder J, Rozner MA, Gottumukkala V, Katz MH, Lee JE, Fleming JB. Serum brain naturietic Peptide measurements reflect fluid balance after pancreatectomy. J Am Coll Surg 214(5):778-87, 2012. e-Pub 2012. PMID: 22440057.
357. Chatterjee D, Rashid A, Wang H, Katz MH, Wolff RA, Varadhachary GR, Lee JE, Pisters PW, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy. Am J Surg Pathol 36(4):552-9, 2012. e-Pub 2012. PMID: 22301496.
358. Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Crane CH, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol 36(3):409-417, 2012. e-Pub 2012. PMID: 22301497.
359. Katz MH, Hu CY, Fleming JB, Pisters PW, Lee JE, Chang GJ. Clinical Calculator of Conditional Survival Estimates for Resected and Unresected Survivors of Pancreatic Cancer. Arch Surg 147(6):513-519. e-Pub 2012. PMID: 22351874.
360. Katz MH, Wang H, Balachandran A, Bhosale P, Crane CH, Wang X, Pisters PW, Lee JE, Vauthey JN, Abdalla EK, Wolff R, Abbruzzese J, Varadhachary G, Chopin-Laly X, Charnsangavej C, Fleming JB. Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. J Gastrointest Surg 16(1):68-78; discussion 78-9, 2012. e-Pub 2012. PMID: 22065318.
361. Tzeng CW, Fleming JB, Lee JE, Xiao L, Pisters PW, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Fogelman DR, Crane CH, Balachandran A, Katz MH. Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy. Ann Surg Oncol 19(6):2045-2053. e-Pub 2012. PMID: 22258816.
362. Zhao Q, Rashid A, Gong Y, Katz MH, Lee JE, Wolf R, Balachandran A, Varadhachary GR, Pisters PW, Wang H, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Pathologic complete response to neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma is associated with a better prognosis. Ann Diagn Pathol 16(1):29-37, 2012. e-Pub 2012. PMID: 22050964.
363. Suetsugu A, Katz M, Fleming J, Truty M, Thomas R, Saji S, Moriwaki H, Bouvet M, Hoffman RM. Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens. Anticancer Res 32(4):1175-1180, 2012. e-Pub 2012. PMID: 22493347.
364. Suetsugu A, Katz M, Fleming J, Truty M, Thomas R, Moriwaki H, Bouvet M, Saji S, Hoffman RM. Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens. J Cell Biochem 113(7):2290-2295, 2012. e-Pub 2012.
365. Chen WC, Weston B, Krishna SG, Gomez G, Rashid A, Katz MH, Lee JE, Raju GS. Prolonged endoscopic loop ligation for removal of gastrointestinal tumors. Endoscopy 45:E1-E2, 2012. e-Pub 2012.
366. Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H. Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Cancer 118(15):3801-3811. e-Pub 2011. PMID: 22180096.
367. Keleman A, Imagawa D, Findeiss L, Hanna M, Tan V, Katz MH, Goodwin S, Lane J, Vajgrt D, Nguyen T, Smith C. Associated vascular injury in patients with bile duct injury during cholecystectomy. The American Surgeon 77(10):1330-1333(4), 2011. e-Pub 2011.
368. Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PW, Vauthey JN, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Histologic grading the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: A predictor for patient outcome. Cancer 118(12):3182-3190. e-Pub 2011. PMID: 22028089.
369. Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H. Posttherapy Pathologic Stage and Survival in Patients with Pancreatic Ductal Adenocarcinoma Treated with Neoadjuvant Chemoradiation. Cancer 118(1):268-277. e-Pub 2011. PMID: 21735446.
370. Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, Evans DB, Lee JE, Fleming JB, Pisters PW. Survival and Quality of Life of Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Interferon-Based Chemoradiation: A Phase II Trial. Annals of Surgical Oncology 18(13):3615-3622. e-Pub 2011. PMID: 21701927.
371. Katz MH, Taylor TH, Al-Refaie WB, Hanna MH, Imagawa DK, Anton-Culver H, Zell JA. Adenosquamous Versus Adenocarcinoma of the Pancreas: A Population-Based Outcomes Analysis. J Gastrointest Surg 15(1):165-174. e-Pub 2010. PMID: 21082275.
372. Katz MH, Merchant NB, Brower S, Branda M, Posner MC, William Traverso L, Abrams RA, Picozzi VJ, Pisters PW, Oncology Group TACOS. Standardization of Surgical and Pathologic Variables is Needed in Multicenter Trials of Adjuvant Therapy for Pancreatic Cancer: Results from the ACOSOG Z5031 Trial. Ann Surg Oncol 18(2):337-344. e-Pub 2010. PMID: 20811779.
373. Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB. Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol 17(7):1794-801, 2010. e-Pub 2010. PMID: 20162463.
374. Tran Cao HS, Bouvet M, Kaushal S, Keleman A, Romney E, Kim G, Fruehauf J, Imagawa DK, Hoffman RM, Katz MH. Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer. Mol Cancer Ther 9(7):2068-78, 2010. e-Pub 2010. PMID: 20606044.
375. Lambert LA, Armstrong TS, Lee JJ, Liu S, Katz MH, Eng C, Wolff RA, Tortorice ML, Tansey P, Gonzalez-Moreno S, Lambert DH, Mansfield PF. Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C. Ann Surg Oncol 16(8):2181-7, 2009. e-Pub 2009. PMID: 19475451.
376. Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16(4):836-47, 2009. e-Pub 2009. PMID: 19194760.
377. Katz MH, Fleming JB, Pisters PW, Lee JE, Evans DB. Anatomy of the superior mesenteric vein with special reference to the surgical management of first-order branch involvement at pancreaticoduodenectomy. Ann Surg 248(6):1098-102, 2008. e-Pub 2008. PMID: 19092356.
378. Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206(5):833-46; discussion 846-8, 2008. e-Pub 2008. PMID: 18471707.
379. Tsuji K, Yang M, Jiang P, Maitra A, Kaushal S, Yamauchi K, Katz MH, Moossa AR, Hoffman RM, Bouvet M. Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude mice. JOP 7(2):193-9, 2006. e-Pub 2006. PMID: 16525203.
380. Bouvet M, Spernyak J, Katz MH, Mazurchuk RV, Takimoto S, Bernacki R, Rustum YM, Moossa AR, Hoffman RM. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. Cancer Res 65(21):9829-33, 2005. e-Pub 2005. PMID: 16267005.
381. Katz MH, Savides TJ, Moossa AR, Bouvet M. An evidence-based approach to the diagnosis and staging of pancreatic cancer. Pancreatology 5(6):576-90, 2005. e-Pub 2005. PMID: 16110256.
382. Katz MH, Bouvet M, Al-Refaie W, Gilpin EA, Moossa AR. Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis. Hepatogastroenterology 51(57):842-6, 2004. e-Pub 2004. PMID: 15143931.
383. Katz MH, Bouvet M, Takimoto S, Spivack D, Moossa AR, Hoffman RM. Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer. Cancer Res 64(5):1828-33, 2004. e-Pub 2004. PMID: 14996746.
384. Alrefaie W, Katz MH, Easter DW, Yi ES, Weidner N, Savides TJ, Moossa AR, Bouvet M. Simultaneous serous cystadenoma of the pancreas and mucinous cystadenoma of the appendix. JOP 5(2):97-100, 2004. e-Pub 2004. PMID: 15007191.
385. Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM, Bouvet M. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer. Clin Exp Metastasis 21(1):7-12, 2004. e-Pub 2004. PMID: 15065597.
386. Zhou W, Katz MH, Deftos LJ, Snyder CS, Baird S, Bouvet M. Metachronous double parathyroid adenomas involving two different cell types: chief cell and oxyphil cell. Endocr Pract 9(6):522-5, 2003. e-Pub 2003. PMID: 14715480.
387. Katz MH, Bouvet M, Takimoto S, Spivack D, Moossa AR, Hoffman RM. Selective antimetastatic activity of cytosine analog CS-682 in a red fluorescent protein orthotopic model of pancreatic cancer. Cancer Res 63(17):5521-5, 2003. e-Pub 2003. PMID: 14500389.
388. Katz MH, Spivack DE, Takimoto S, Fang B, Burton DW, Moossa AR, Hoffman RM, Bouvet M. Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter. Ann Surg Oncol 10(7):762-72, 2003. e-Pub 2003. PMID: 12900367.
389. Katz MH, Takimoto S, Spivack D, Moossa AR, Hoffman RM, Bouvet M. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res 113(1):151-60, 2003. e-Pub 2003. PMID: 12943825.
390. Zhou W, Katz MH, Deftos L, Snyder C, Baird S, Bouvet M. Metachronous double parathyroid adenomas involving two different cell types: chief and oxyphil cell: a case report. Endocrine Practice, 9(6):522-525, 2003. e-Pub 2003.
391. al ME. AP1 transcription factor enrichment facilitates resistance to histone deacetylase inhibitors in pancreatic cancers.
392. Mohindroo C, Baydogan S, Agarwal P, Wright R, Prakash L, Mork M, Klein A, Laheru D, Maxwell J, Katz MHG, Dasari A, Kim MP, He J, McAllister F, de Jesus-Acosta A. Germline Testing identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.
393. al EE. Clinical, Pathologic, and Genetic Characteristics of Small Bowel Adenocarcinoma – A Multi-Institutional Study.
394. al HE. Impact of Adjuvant Chemotherapy in IPMN-derived PDAC.
395. al SE. Preoperative chemotherapy, radiotherapy, and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer: an evidence-based approach. Nature Reviews Gastroenterology and Hepatology.

Invited Articles

1. Jain AJ, Maxwell JE, Katz MHG, Snyder RA. Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma. Cancers (Basel) 15(16), 2023. e-Pub 2023. PMID: 37627202.
2. Spitzer HV, Bohan PMK, Carpenter EL, Adams AM, Chang SC, Grunkemeier G, Vreeland TJ, Tzeng CD, Katz MH, Nelson DW. ASO Visual Abstract: Impact of Adherence to Operative Standards and Stage-Specific Guideline-Recommended Therapy in Non-metastatic Pancreatic Adenocarcinoma. Annals of Surgical Oncology 30(11):6671-6672, 2023. e-Pub 2023. PMID: 37543545.
3. Katz MHG. Selective not routine use. International Journal of Radiation Oncology, Biology, Physics 116(4):707, 2023. e-Pub 2023. PMID: 37355304.
4. Eshmuminov D, Aminjonov B, Palm RF, Malleo G, Schmocker RK, Abdallah R, Yoo C, Shaib WL, Schneider MA, Rangelova E, Choi YJ, Kim H, Rose JB, Patel S, Wilson GC, Maloney S, Timmermann L, Sahora K, Rössler F, Lopez-Lopez V, Boyer E, Maggino L, Malinka T, Park JY, Katz MHG, Prakash L, Ahmad SA, Helton S, Jang JY, Hoffe SE, Salvia R, Taieb J, He J, Clavien PA, Held U, Lehmann K. ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review. Annals of Surgical Oncology 30(7):4431-4432, 2023. e-Pub 2023. PMID: 37067744.
5. Concors SJ, Katz MHG, Ikoma N. Minimally Invasive Pancreatectomy: Robotic and Laparoscopic Developments. Surg Oncol Clin N Am 32(2):327-342, 2023. e-Pub 2023. PMID: 36925189.
6. Allen CJ, Katz MHG. ASO Author Reflections: Can We Measure 'Value'?. Ann Surg Oncol 29(11):6546-6547, 2022. e-Pub 2022. PMID: 35254580.
7. Francescatti AB, Hunt KK, Katz MHG, of Surgeons CSSPOTAC. ASO Author Reflections: Technical Standards for Cancer Surgery: From "How I Do It" to "How We Do It". Ann Surg Oncol 29(11):6559-6560, 2022. e-Pub 2022. PMID: 35288816.
8. Seo YD, Katz MHG. Preoperative therapy for pancreatic adenocarcinoma-precision beyond anatomy. Cancer 128(16):3041-3056, 2022. e-Pub 2022. PMID: 35679197.
9. Allen CJ, Smith GL, Prakash L, Volk RJ, Ikoma N, Aloia TA, Gottumukkala V, Katz MHG. ASO Visual Abstract: What is "Value"? Results of a Survey of Cancer Patients and Providers. Annals of Surgical Oncology, 2022. e-Pub 2022. PMID: 35430655.
10. Ikoma N, Lee JE, Katz MHG. ASO author reflections: accelerating the learning curve of robotic pancreatectomy and gastrectomy through a composite robotic foregut surgical oncology program. Ann Surg Oncol 29(1):286-287, 2022. e-Pub 2022. PMID: 34595667.
11. Snyder RA, Ahmad S, Katz MHG. Pancreas cancer trials for early stage disease: surgeons leading therapeutic cooperative group trials. J Surg Oncol 125(1):75-83, 2022. e-Pub 2022. PMID: 34586635.
12. Kothari AN, DiBrito SR, Lee JJ, Caudle AS, Clemens MW, Gottumukkala VN, Katz MHG, Offodile AC, Uppal A, Team D, Chang GJ. ASO Visual Abstract: Surgical Outcomes for Cancer Patients Undergoing Elective Surgery after Recovering from Mild to Moderate SARS-CoV-2 Infection. Annals of Surgical Oncology 28(Suppl 3):591, 2021. e-Pub 2021. PMID: 34378092.
13. Zheng L, Francescatti A, Deming S, Vreeland TJ, Boughey JC, Snyder RA, Hunt KK, Katz MHG. ACS Cancer Research Program: Synoptic reporting for cancer surgery: current requirements and future state. Bulletin of the American College of Surgeons, 2021. e-Pub 2021.
14. Patel SH, Katz MHG, Ahmad SA. The Landmark Series: Preoperative therapy for pancreatic cancer. Ann Surg Oncol 28(8):4104-4129, 2021. e-Pub 2021. PMID: 34047859.
15. Katz MHG. Commentary: Periadventitial dissection of the superior mesenteric artery at pancreatoduodenectomy for locally advanced pancreatic cancer. Surgery 169(5):1034-1035, 2021. e-Pub 2021. PMID: 33353732.
16. Gaskill CE, Maxwell J, Ikoma N, Kim MP, Tzeng CW, Lee JE, Katz MHG. History of preoperative therapy for pancreatic cancer and the MD Anderson experience. J Surg Oncol 123(6):1414-1422, 2021. e-Pub 2021. PMID: 33831256.
17. Parker NH, Katz MHG. ASO Author Reflections: It is Time to Prioritize Exercise in Pancreatic Cancer Survivorship. Ann Surg Oncol 28(4):2310-2311, 2021. e-Pub 2021. PMID: 32886285.
18. Maxwell JE, Katz MHG. Radiotherapy for Resectable and Borderline Resectable Pancreas Cancer: When and Why?. J Gastrointest Surg 25(3):843-848, 2021. e-Pub 2021. PMID: 33205307.
19. Perri G, Prakash L, Katz MHG. Defining and treating borderline resectable pancreatic cancer. Curr Treat Options Oncol 9(71):71, 2020. e-Pub 2020. PMID: 32725270.
20. Perri G, Katz MHG. ASO Author Reflections: The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer. Annals of Surgical Oncology, 2020. e-Pub 2020. PMID: 32358700.
21. Perri G, Prakash LR, Katz MHG. Response to Preoperative Therapy in Localized Pancreatic Cancer. Front Oncol 10:516, 2020. e-Pub 2020. PMID: 32351893.
22. Perri G, Prakash LR, Katz MHG. Pancreatic neuroendocrine tumors. Current Opinion in Gastroenterology 35(5):468-477, 2019. e-Pub 2019. PMID: 31306159.
23. Simoneau E, Katz MH, Lee JE, Tzeng CD. ASO Author Reflections: Temporary Mesocaval Shunt: Indications and Technique for Safe Resection of Pancreatic Tumors With Mesenteric Venous Occlusion. Annals of Surgical Oncology, 2019. e-Pub 2019. PMID: 30859352.
24. Katz MHG, Varadhachary GR. Borderline resectable pancreatic cancer: at the crossroads of precision medicine. Cancer 125(10):1584-1587, 2019. e-Pub 2019. PMID: 30673119.
25. Vreeland TJ, Katz MHG. Timing of pancreatic resection and patient outcomes: is there a difference?. Surgical Clinics of North America 98(1):57-71, 2018. e-Pub 2018. PMID: 29191278.
26. Katz MH, Ahmad SA, Boughey JC. Two studies pave the way for preoperative therapy in pancreatic cancer patients. Bulletin of the American College of Surgeons 101(8):57-60, 2017. e-Pub 2017. PMID: 28941435.
27. Prakash L, Katz MH. Multimodality management of borderline resectable pancreatic adenocarcinoma. Chinese Clinical Oncology 3(27), 2017. e-Pub 2017. PMID: 28705004.
28. Uy GL, Katz MHG, Boughey JC. Junior investigators: Get engaged in the Alliance for Clinical Trials in Oncology. Bulletin of the American College of Surgeons 102(4):62-63, 2017. e-Pub 2017. PMID: 28920650.
29. Katz MH, Ahmad SA, Boughey JC. Improving resection rates in borderline resectable pancreatic cancer: Pilot study shows favorable results. Bull Am Coll Surg 100(10):39-41, 2015. e-Pub 2015. PMID: 26552293.
30. Schwarz L, Katz MH. Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma. Hematology Oncology Clinics of North America 29(4):727-740, 2015. e-Pub 2015. PMID: 26226907.
31. Martin LW, Veeramachaneni NK, Katz MH, You YN, Boughey JC, Nelson H, Hunt KK. New manual for cancer surgery issued: Operative Standards for Cancer Surgery. Bulletin of the American College of Surgeons 100(6):43-4, 2015. e-Pub 2015. PMID: 26182523.
32. Liles JS, Katz MHG. Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma. Expert Review of Anticancer Therapy 14(8):919-929, 2014. e-Pub 2014.
33. Katz MH, Crane CH, Varadhachary G. Management of Borderline Resectable Pancreatic Cancer. Semin Radiat Oncol 24(2):105-112, 2014. e-Pub 2014.
34. Katz MHG, Landry J, Kindler HL. Current controversies in the stage-specific multidisciplinary management of pancreatic cancer. ASCO Educational Book. e-Pub 2014.
35. Cooper AB, Tzeng CW, Katz MH. Treatment of borderline resectable pancreatic cancer. Curr Treat Options Oncol 14(3):293-310. e-Pub 2013. PMID: 23793524.
36. Katz MH, Ahmad S, Nelson H. Borderline resectable pancreatic cancer: pushing the technical limits of surgery. Bull Am Coll Surg 98(1):61-63, 2013. e-Pub 2013. PMID: 23359915.
37. Tamm EP, Balachandran A, Bhosale PR, Katz MH, Fleming JB, Lee JH, Varadhachary GR. Imaging of pancreatic adenocarcinoma: update on staging/resectability. Radiol Clin North Am 50(3):407-28, 2012. e-Pub 2012.
38. Katz MH, Fleming JB, Lee JE, Pisters PW. Current status of adjuvant therapy for pancreatic cancer. Oncologist 15(11):1205-13, 2010. e-Pub 2010. PMID: 21045189.
39. Yamamoto M, Imagawa DK, Katz MH. Multidisciplinary management of resectable adenocarcinoma of the pancreatic head. Expert Rev Anticancer Ther 10:1611-21, 2008. e-Pub 2008. PMID: 18925853.
40. Katz MH, Hwang R, Fleming D, Evans DB. TNM staging of pancreatic adenocarcinoma. CA: A Journal for Clinicians 58(2):111-125, 2008. e-Pub 2008.
41. Katz M, Vauthey JN. Potentially curable metastatic colorectal cancer. Current Oncology 8(10):1611-1621, 2008. e-Pub 2008.
42. Katz MH, Choi EA, Pollock RE. Current concepts in multimodality therapy for retroperitoneal sarcoma. Expert Rev Anticancer Ther 7(2):159-68, 2007. e-Pub 2007. PMID: 17288527.
43. Katz MH, Barone RM. The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies. Surg Oncol Clin N Am 12(3):673-88, 2003. e-Pub 2003. PMID: 14567024.
44. Katz MHG, Merchant NB. Borderline resectable pancreatic cancer. GI ASCO Ed Book.

Review Articles

1. Cardell CF, Dekker EN, Katz MHG, Tzeng CD. The Landmark Series: Neoadjuvant Therapy for Resectable Pancreatic Cancer. Ann Surg Oncol 32(9):6467-6476, 2025. e-Pub 2025. PMID: 40624308.
2. Perri, G, Engstrand, J, Wright, RD, Bronzwaer, SF, Kroese, TE, Huang, B, Acidi, B, Vitale, A, Tran Cao, HS, van Hillegersberg, R, Nilsson, M, Sparrelid, E, Katz, MH, Marchegiani, G, Cillo, U. The evolving concept of conversion surgery for upfront unresectable upper gastrointestinal and hepato-pancreato-biliary cancers. BJS open 9(4), 2025. e-Pub 2025. PMID: 40631805.
3. Seo YD, Katz MHG, Snyder RA. The Landmark Series: The Future of Pancreatic Cancer Clinical Trials. Ann Surg Oncol 32(4):2777-2785, 2025. e-Pub 2025. PMID: 39815074.
4. Stoop TF, Theijse RT, Seelen LWF, Groot Koerkamp B, van Eijck CHJ, Wolfgang CL, van Tienhoven G, van Santvoort HC, Molenaar IQ, Wilmink JW, Del Chiaro M, Katz MHG, Hackert T, Besselink MG, Pancreatic Cancer ICGOLA. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer. Nat Rev Gastroenterol Hepatol 21(2):101-124, 2024. e-Pub 2024. PMID: 38036745.
5. Schleimer, LE, Ethun, CG, Court, CM, Chou, JF, Mcintyre, S, Walch, H, Sigel, C, Sharib, J, Masoud, S, Chen, W, Aveson, VG, Wang, H, Katz, MH, Overman, MJ, Lidsky, ME, Maithel, SK, Poultsides, GA, Fields, RC, Gönen, M, Jarnagin, W. A novel classification of small bowel adenocarcinoma based on a hidden genome classifier. Journal of Clinical Oncology 42:724, 2024. e-Pub 2024.
6. Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JB. Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg 207(1):106-20, 2008. e-Pub 2008. PMID: 18589369.
7. Mortenson MM, Katz MH, Tamm EP, Bhutani MS, Wang H, Evans DB, Fleming JB. Current diagnosis and management of unusual pancreatic tumors. Am J Surg 196(1):100-13, 2008. e-Pub 2008. PMID: 18466869.
8. Du E, Katz M, Weidner N, Yoder S, Moossa AR, Shabaik A. Ampullary pancreatoblastoma in an elderly patient: a case report and review of the literature. Arch Pathol Lab Med 127(11):1501-1505, 2003. e-Pub 2003. PMID: 14567752.
9. Katz MH, Bouvet M. Novel gene therapy approaches to pancreatic cancer. Int J Gastrointest Cancer 33(1):89-97, 2003. e-Pub 2003. PMID: 12909741.

Professional Educational Materials

1. Katz MH, El-Rayes BF, Landry JC. Expert Perspectives: Selecting Initial Treatment Strategies in Pancreatic Cancer. Partners in Pancreatic Cancer, 2015.
2. Katz MH. Defining resectability in pancreatic cancer, 2013.
3. Katz MH. Staging pancreatic cancer, 2013.
4. Katz MH. Introduction to Pancreatic Cancer, 2013.
5. Katz MH. Borderline resectable pancreatic cancer. OncLive TV videocast, January 11, 2013, 2013.
6. Katz MH, Fleming JB. Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg, 2008.

Other Articles

1. Thomas KK, Francescatti AB, Vreeland TJ, Teshome MK, Morris AM, Hunt KK, Katz MHG, Villano AM Correction: Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. Ann Surg Oncol 31(7):4565, 2024. PMID: 38662097.
2. Mavros MN, Moris D, Karanicolas PJ, Katz MHG, O'Reilly EM, Pawlik TM Clinical Trials of Systemic Chemotherapy for Resectable Pancreatic Cancer: A Review. JAMA Surg 156(7):663-672, 2021. PMID: 33787841.
3. Collaborative C SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. British Journal of Surgery 108(9):1056-1063, 2021. PMID: 33761533.
4. Collaborative G Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anesthesia, 2021.
5. Pieterman CRC, Sadowski SM, Maxwell JE, Katz MHG, Lines KE, Heaphy CM, Tirosh A, Blau JE, Perrier ND, Lewis MA, Metzcar JP, Halperin DM, Thakker RV, Valk GD HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives. Endocrine Related Cancer, 2020. PMID: 32069215.
6. Park KU, Mamounas EP, Katz MHG, Unzeitig G, Carpizo D, You YN, Francescatti A, Hunt KK, Boughey JC Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles. Ann Surg Oncol 27(7):2269-2275, 2020. PMID: 32318946.
7. Roland CL, Grubbs EG, Katz MHG, Teshome M, Hunt KK, Tzeng CW Clinical trials-designing, implementing, and collaborating. J Surg Oncol 122(1):25-28, 2020. PMID: 32149390.
8. Collaborations DBTLWTACP, disease sections IFSSAWAIT ACS Guidelines for Triage and Management of Elective Cancer Surgery Cases During the Acute and Recovery Phases of Coronavirus Disease 2019 (COVID-19) Pandemic, 2020.
9. Marsh RW, Talamonti MS, Katz MH, Herman JM Pancreatic cancer and FOLFIRINOX: a new era and new questions. Cancer Medicine 4(6):853-863, 2015. PMID: 25693729.
10. Balachandran A, Tamm EP, Bhosale PR, Patnana M, Vikram R, Fleming JB, Katz MH, Charnsangavej C Pancreatic neuroendocrine neoplasms: diagnosis and management. Abdom Imaging 38(2):342-57, 2013. PMID: 22707246.

Editorials

1. Francescatti, A, Hieken, TJ, Katz, MH. Operative Standards for Cancer Care. Annals of surgical oncology 31(13):8476-8478, 2024. PMID: 39361174.
2. Thomas KK, Francescatti AB, Vreeland TJ, Teshome MK, Morris AM, Hunt KK, Katz MHG, Villano AM. Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. Annals of Surgical Oncology 31(1):6-9, 2023. PMID: 37880516.
3. Allen CJ, Johnson FM, In H, Katz MHG, Snyder RA. Shifting the focus: value based care in surgical oncology. Ann Surg Oncol 30(7):3871-3874, 2023. PMID: 37014556.
4. Allen CJ, Johnson FM, In H, Katz MHG, Snyder RA. Shifting the Focus: Value-Based Care in Surgical Oncology. Annals of Surgical Oncology 30(7):3871-3874, 2023. PMID: 37014556.
5. Adesoye T, Katz MHG, Offodile AC. Meeting Trial Participants Where They Are: Decentralized Clinical Trials as a Patient-Centered Paradigm for Enhancing Accrual and Diversity in Surgical and Multidisciplinary Trials in Oncology. JCO Oncol Pract 19(6):OP2200702, 2023. PMID: 36821820.
6. Lyu HG, Gordon WJ, Huey RW, Katz MHG. Leveraging the 21st Century Cures Act to Improve Cancer Care, Patient Engagement, and Data Collection. JCO Oncol Pract 18(12):788-790, 2022. PMID: 36219810.
7. Hester CA, Katz MHG. Thumbprinting Locally Advanced Pancreatic Cancer: Have We Developed the Optimal Staging System?. Ann Surg Oncol 28(11):5808-5810, 2021. PMID: 34019183.
8. Katz MHG. Perioperative Clinical Trials for Pancreatic Cancer in the National Clinical Trials Network. Annals of Surgical Oncology, 2019. PMID: 31552616.
9. Kim MP, Katz MHG. Perioperative Therapy for Borderline Resectable Pancreatic Cancer: What and When?. Annals of Surgical Oncology 26(6):1596-1597. PMID: 30680479.
10. Ikoma N, Katz MHG. Improving Outcomes After Distal Pancreatectomy with Celiac Axis Resection (DP-CAR): As Always, it is All About Patient Selection. Ann Surg Oncol 26(3):703-704, 2018. PMID: 30539493.
11. Katz MH, Kim MP, Tzeng CW, Lee JE. Preoperative Chemoradiation for Borderline Resectable Pancreatic Cancer: The New Standard?. Annals of Surgery 268(2):223-224, 2018. PMID: 29672417.
12. Katz MH. Should Fear of Adverse Events Influence the Decision to Administer Preoperative Therapy to Patients with Pancreatic Cancer?. Annals of Surgical Oncology 25(3):588-590, 2017. PMID: 29243201.
13. Katz MH. Preoperative Therapy for Pancreatic Cancer: The Tide Is Turning. Journal of Oncology Practice 12(9):783-784, 2016. PMID: 27621328.
14. Katz MH, Pisters PW, Lee JE, Fleming JB. Borderline resectable pancreatic cancer: what have we learned and where do we go from here?. Annals of Surgical Oncology 18(3):608-10, 2011. PMID: 21136179.

Abstracts

1. Katz MHG, Varadhachary GR, Bauer TW, Acquavella N, Merchant NB, Le TM, Javle MM, Shroff RT, Overman MJ, Fogelman DR, Petroni GR, Singluff CL, Rahma OE. Preliminary safety data from a randomized multicenter phase Ib/II study of neoadjuvant chemoradiation therapy (CRT) alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic cancer. JCO 35(suppl; abstr 4125), 2017. e-Pub 2017.
2. Katz MHG, Ahmad S, Herman J, Marsh R, Collisson E, Shcwartz L, Martin R, Conway W, Truty M, Kindler H, Am L, Philip P, Bekaii-Saab T, Cardin D, LoConte N, Venook AP. Preoperative modified FOLFIRINOX (mFOLFIRINOX) followed by chemoradiation (CRT) for borderline resectable (BLR) pancreatic cancer (PDAC): Initial results from Alliance Trial A021101. J Clin Oncol 33(suppl):Abstr 4008, 2015. e-Pub 2015.
3. Wang H, Estrella JS, Chaterjee D, Katz MH, Rashid A, Wang H, Wolff RA, Varadhachary GR, Lee JE, Pisters PW, Abbruzzese JL, Fleming JB. Hepatobiliary/Pancreas pathology: SY11-3 Pancreatic ductal adenocarcinoma: neoadjuvant therapies and pathology. Pathology 46(Suppl 2):S25, 2014. e-Pub 2014.
4. Lee S, Reha JL, C-W T, Massarweh NN, Chang GJ, Hetz SP, Fleming JB, Lee JE, Katz MHG. Race does not impact pancreatic cancer treatment and survival in an equal access federal healthcare system. Annals of Surgical Oncology, 2013. e-Pub 2013.
5. Roland C, Katz MH. Influence of preoperative chemoradiation on biologically significant parameters in ampullary carcinoma. Society of Surgical Oncology, 2012. e-Pub 2012.
6. Thomas R, Katz MH. Selective re-operation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. Society of Surgical Oncology, 2012. e-Pub 2012.
7. Tzeng C, Fleming J, Lee J, Xiao L, Pisters P, Vauthey J, Abdalla E, Wolff R, Varadhachary G, Fogelman D, Crane C, Balachandran C, Katz MH. Operability classifications predict outcomes of patients with anotomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. Society of Surgical Oncology, 2012. e-Pub 2012.
8. Rafeeq S, Overman J, Katz MH, Royal R, Mansfield P, Fournier K, Lambert L. Lymphatic metastasisin well-differentiated appendiceal cancer: prognostic factors and associations with outcome. GI ASCO, 2012. e-Pub 2012.
9. Rafeeq S, Overman J, Katz MH, Royal R, Mansfield P, Fournier K, Lambert L. Lymphatic metastasisin well-differentiated appendiceal cancer: prognostic factors and associations with outcome. Society of Surgical Oncology, 2012. e-Pub 2012.
10. Petzel MQ, Parker NH, Valentine AD, Simard S, Nogueras-Gonzalez GN, Fleming JB, Lee JE, Pisters PW, Vauthey J, Katz MH. Fear of cancer recurrence and quality of life among survivors of pancreatic and periampullary neoplasms. Annals of Surgical Oncology 19 S1:S155-S156, 2012. e-Pub 2012.
11. Thomas R, Katz MH. Selective re-operation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. GI ASCO, 2012. e-Pub 2012.
12. Tzeng C, Fleming J, Lee J, Xiao L, Pisters P, Vauthey J, Abdalla E, Wolff R, Varadhachary G, Fogelman D, Crane C, Balachandran C, Katz MH. Operability classifications predict outcomes of patients with anotomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. GI ASCO, 2012. e-Pub 2012.
13. Thomas RM, Truty MJ, Kim MB, Kang Y, Zang R, Katz MH, Lee JE, Fleming JB. Correlation of a personalized patient-derived pancreatic adenocarcinoma xenograft program to patient outcomes after curative resection. Pancreas Club, 2012. e-Pub 2012.
14. Truty MUJ, Katz MH, Lee JE, Fleming JB. Portal decompression procedures during pancreaticoduodenectomy. Pancreas Club, 2012. e-Pub 2012.
15. Petzel M, Parker N, Valentine A, Simard S, Nogueras-Gonzalez G, Lee JE, Pisters PW, Vauthey JN, Fleming JB, Katz MH. Fear of recurrence and quality of life among survivors of pancreatic and periampullary neoplasms. Pancreas Club, 2012. e-Pub 2012.
16. Tzeng CW, Katz MH. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodality therapy. Pancreas Club, 2012. e-Pub 2012.
17. Thomas RM, Katz MH. Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. Pancreas Club, 2012. e-Pub 2012.
18. Abbott DE, Tzeng CW, Merkow R, Cantor S, Katz MH, Bentrem DJ, Bilimoria K, Crane C, Varadhachary G, Evans D, Fleming JB. Neoadjuvant chemoradiation versus surgery first for resectable pancreatic head adenocarcinoma- an economic and outcome analysis. Pancreas Club, 2012. e-Pub 2012.
19. Shroff S, Overman M, Rashid A, Wang H, Schroff R, Hamilton S, Katz MH, Lee JE, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Loss of PTEN expression is associated with poor prognosis in patients with ampullary adenocarcinoma. Laboratory Investigation 92(Supp 1):448A, 2012. e-Pub 2012.
20. Zenali MJ, Overman M, Rashid A, Hamilton SR, Broaddus R, Katz MH, Abbruzzese JL, Fleming JB, Wang, H. Clinicopathological review of 62 cases of primary duodenal adenocarcinoma. Laboratory Investigation 92(Supp 1):187A, 2012. e-Pub 2012.
21. Foo W, RAshid A, Wang H, Hamilton S, Katz MH, Lee JE, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Loss of PTEN expression in pancreatic ductal adenocarcinoma is associated with poor survival. Laboratory Investigation 92(Supp 1):442A-443A, 2012. e-Pub 2012.
22. Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PWT, Vauthey JN, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Histologic grading the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Laboratory Investigation 92(Supp 1):441A, 2012. e-Pub 2012.
23. Katz M. Incidence and impact of a close superior mesenteric artery margin following pancreaticoduodenectomy for adenocarcinoma. Digestive Disease Week, 2011. e-Pub 2011.
24. Yang AD, Katz MH, Lin H, Chopin-Laly X, Abdalla EK, Vauthey JN, Pisters PW, Varadhachary GR, Wolff RA, Crane CH, Lee JE, Fleming JB. Preoperative Therapy Improves Lymph Node Ratio in Pancreatic Adenocarcinoma. Society of Surgical Oncology, 2011. e-Pub 2011.
25. Katz MH. Analysis of Free Form Radiology Dictations for Completeness and Clarity for Pancreatic Cancer Staging by Evaluating Against the RSNA CT Oncology Primary Pancreas Mass Dictation Template. RSNA 97th Scientific Assembly and Annual Meeting, 2011. e-Pub 2011.
26. Estrella JS, Rashid A, Katz MH, Lee JE, Wolff RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Fleming JB, Abbruzzese JL, Wang H. Posttherapy pathologic stage and number of positive lymph nodes predict survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. Laboratory Investigation 91(Supp 1):359A, 2011. e-Pub 2011.
27. Katz MH, Merchant NB, Brower S, Campbel M, Posner M, Traverso LW, Abrams RA, Picozzi VJ, Pisters PW. Standardization and documentation of surgical and pathologic variables in a multi-institutional trial of adjuvant therapy for pancreatic cancer: results from ACOSOG Z5031. Ann Surg Onc 17(Supp 1):S36, 2010. e-Pub 2010.
28. Tran Cao HS, Bouvet M, Romney E, Kaushal S, Keleman A, Kim G, Fruehauf J, Imagawa DK, Hoffman RM, Katz MH. Low dose metronomic gemcitabine has high antimetastatic efficacy in an orthotopic mouse model of pancreatic cancer. Annals of Surgical Oncology 17(1S):S65, 2010. e-Pub 2010.
29. Lambert LA, Katz MH, Lambert DH, Overman MJ, Eng C, Wolff RA, Yao J, Ng C, Beaty K, Hernandez E, Mansfield PF. Clinical and pathological characteristics of adenocarcinoid tumors of the appendix: more adeno, less carcinoid. Ann Surg Onc 16(1):67, 2009. e-Pub 2009.
30. Katz MH, Fleming JB, Sun CC, Wolff RA, Crane CH, Evans DB, Varadhachary GR. Preoperative CA 19-9 in the neoadjuvant treatment of resectable pancreatic cancer. Poster presentation at the 42nd Annual Meeting of the Pancreas Club, 2008. e-Pub 2008.
31. Katz MH, Yao J, Anaya D, Curley S, Abdalla EK, Vauthey JN. Multi-modality therapy of hepatic neuroendocrine metastases. Annual Meeting of the American Hepatopancreatobiliary Association, 2008. e-Pub 2008.
32. Katz MH, Fleming JB, Hwang RF, Sun CC, Wolff RA, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Long term survival after multidisciplinary management of resectable pancreatic adenoarcinoma. Ann Surg Onc 15(Supp 2):6, 2008. e-Pub 2008.
33. Lambert LA, Armstrong TA, Lee JJ, Liu S, Katz MHG, Eng C, Wolff RA, Smith ML, Diaz P, Moreno-Gonzalez S, Mansfield PF. Female sex and standardized mitomycin-c dose are associated with increased risk of neutropenia after hyperthermic intraperitoneal chemotherapy. Ann Surg Onc 15(Supp 2):55-56, 2008. e-Pub 2008.
34. Katz MH, Mansfield PF, Eng C, Wolff RA, Ng C, Lambert L. Incidence and impact of lymph node and non-peritoneal metastases in non-carcinoid epithelial tumors of the appendix. Ann Surg Onc 15(Supp 2):60, 2008. e-Pub 2008.
35. Katz MH, Mansfield PF, Eng C, Wolff RA, Diaz P, Ng C, Lambert L. Is there a role for neoadjuvant chemotherapy in the management of non-carcinoid epithelial neoplasms of the appendix?. Journal of Clinical Oncology, 2007 ASCO Meeting Proceedings Part 1 25(18S):15115, 2007. e-Pub 2007.
36. Bouvet M, Spernyak J, Katz MH, Mazurchuk RV, Takimoto S, Bernacki R, Rustum YM, Moossa AR, Hoffman RM. High correlation of whole-body red fluorescent protein imaging and magnetic resonance imaging on an orthotopic model of pancreatic cancer. Cancer Research 65(21):9829-9833, 2005. e-Pub 2005.
37. Katz MH, Savides TJ, Moossa AR, Bouvet M. An evidence-based approach to the diagnosis and staging of pancreatic cancer. Pancreatology 5(6):576-590, 2005. e-Pub 2005.
38. Bouvet M, Amoh Y, Takimoto S, Katz MH, Yang M, Moossa AR, Hoffman RM. New dual-color fluorescence models of RFP orthotopic human pancreatic cancer implanted in B-actin-driven and nestin-driven GFP nude mice. Proceedings of the 96th Annual Meeting of the American Association for Cancer Research, 2005. e-Pub 2005.
39. Katz MH, Spernyak J, Takimoto S, Moossa AR, Mazurchuk R, Hoffman RM, Bouvet M. Comparison of fluorescent protein imaging (FPI) and MRI of pancreatic tumors in nude mice. Proceedings of the 96th Annual Meeting of the American Association for Cancer Research, 2005. e-Pub 2005.
40. Katz MH, Bouvet M, Takimoto S, Spivack D, Moossa AR, Hoffman RM. Survival efficacy of adjuvant cytosine-analogue CS-682 in a fluorescent orthotopic model of human pancreatic cancer. Cancer Research 64(5):1828-1833, 2004. e-Pub 2004.
41. Katz MH, Spivack D, Takimoto S, Moossa A, Jiang P, Baranov E, Hoffman RM, Bouvet M. Dual color, in vivo imaging of gene expression in a pancreatic cancer model. Gastroenterology 124(4S):A805, 2003. e-Pub 2003.
42. Katz MH, Spivack DE, Takimoto S, Fang BL, Burton DW, Moossa AR, Hoffman RM, Bouvet M. Gene therapy of pancreatic cancer with green fluorescent protein and tumor necrosis factor-related apoptosis-inducing ligand fusion gene expression driven by a human telomerase reverse transcriptase promoter. Ann Surg Onc 10(1S):S13, 2003. e-Pub 2003.
43. Capello M, Bantis LE, Scelo G, Zhao Y, Dhillon DS, Wang H, Abbruzzese JL, Maitra A, Tempero MA, Brand R, Firpo MA, Mulvihill S, Katz MH, Brennan P, Feng Z, Hanash SM, Taguchi A. Sequential Validation of Blood-Based Protein Biomarker candidates for Early-Stage Pancreatic Cancer. 2016 AACR Annual Meeting, New Orleans, LA.

Book Chapters

1. Ikoma, N, Fujii, Y, Katz, MH. Minimally invasive surgical approaches, 209-217, 2022.
2. Allen C, Perri G, Katz MHG. Cooperative Clinical Trials. In: Success in Academic Surgery. Springer, 2020.
3. Denbo JW, Kim MP, Katz MH. Pancreatic Ductal Adenocarcinoma. In: The MD Anderson Surgical Oncology Handbook. 6th. Walters Kluwer, 398-412, 2018.
4. Cloyd JM, Katz MHG. Preoperative therapy for pancreatic ductal adenocarcinoma. In: Hepato-pancreato-biliary and transplant surgery: practical management of dilemmas, 2018.
5. Cloyd JM, Katz MHG. Approaches to retroperitoneal dissection during pancreatoduodenectomy. In: Optimizing outcomes for liver and pancreas surgery. Springer, 2018.
6. Gagel AC, Katz MH. Pancreaticojejunostomy - How I do it. In: Surgery for pancreatic and periampullary cancer. Springer Nature, 2018.
7. Tran Cao H, Katz MH. Robotic hepatopancreatic surgery. In: Laparoscopic Liver, Pancreas, Biliary Surgery: Textbook and Atlas. Wiley, 2017.
8. Raghav K, Katz MHG, Overman MJ. Uncommon Cancer of the Small Bowel. In: Textbook of Uncommon Cancer, Fifth Edition. Fifth. Oxford, 416-428, 2017.
9. Debashish B, Katz, MH, Fleming JB. Pancreatic Adenocarcinoma. In: MD Anderson Handbook for Surgical Oncology. 5th. Lippincott Williams & Wilkins, 355-368, 2016.
10. Katz MH, Bednarski B. Principles of Surgery. In: UICC Manual of Clinical Oncology. 9th edition. Wiley-Blackwell, 98-107, 2015.
11. Cooper AB, Tzeng CWD, Katz MHG. Surgical aspects of pancreatic cancer. In: Cancer Consult: Expertise for Clinical Practice. Wiley Blackwell, 723-728, 2014.
12. Fleming JB, Katz MH, Hwang RH, Varadhachary JB. Pancreatic Cancer. In: 60 years of survival outcomes at the University of Texas MD Anderson Cancer Center. Springer, 119-132, 2012.
13. Katz MH, Lee JE, Fleming JB, Pisters PW. Commentary on Pancreatic Adenocarcinoma. In: Surgery: Evidence Based Practice. Peoples Medical Publishing House, 2012.
14. Raghav KP, Katz MH, Overman MJ. Cancers of the Small Bowel. In: Textbook of uncommon cancer. Fourth. The University of Texas M. D. Anderson Cancer Center, 441-452, 2012.
15. Katz MHG. Borderline resectable pancreatic cancer and techniques of vascular resection. In: Textbook of Surgical Oncology. McGraw-Hill, 2012.
16. Katz MG, Fleming JB, Lee JH, Pisters PW. Borderline Resectable Pancreatic Adenocarcinoma. In: Pancreatic Cancer. Elsevier, 2011.
17. Abdalla EK, Veerapong J, Katz MH. Liver metastases: surgical management and liver directed therapies. In: Handbook of Gastroenteropancreatic and thoracic neuroendocrine tumors. Second Edition. Bioscientifica, 2011.
18. Katz MH, Moossa AR, Bouvet M. Laparoscopic staging of pancreatic cancer. In: MD Anderson Solid Tumor Oncology Series: Pancreatic Cancer. Springer, 2008.
19. Katz MH, Feig BW, Bouvet M. Splenectomy for hematologic malignancy. In: Advanced Therapy in Surgical Oncology. New York, 2007.
20. Katz MH, Bouvet M. Pancreatitis and pancreatic injuries. In: Trauma: Resuscitation, Anesthesia and Critical Care. Marcel Dekker, 2007.
21. Katz MH, Moossa AR, Bouvet M. Serologic diagnosis of pancreatic cancer. In: Pancreatic Cancer. Jones and Bartlett Publishers, 2005.

Books (edited and written)

1. Bhutani, M, Katz, MH, Maitra, A, Herman, JM, Wolff, RA. Pancreatic Cancer, 2022.
2. Multiple. Operative Standards for Cancer Surgery. Lippincott Williams Wilkins, 2022.
3. Multiple. Pancreatic Cancer: A multidisciplinary approach. Springer, 2022.
4. authors M. Operative Standards for Cancer Surgery. Walters Kluwer, 2018.
5. authors M. Multimodality Management of Borderline Resectable Pancreatic Cancer. Springer, 2015.
6. authors M. Operative Standards for Cancer Surgery. Wolters Kluwer, 2015.

Letters to the Editor

1. Yousef M, Yousef A, Hurd MW, Pillai A, Chowdhury S, Snyder R, Knafl M, Lewis RL, Roy PM, Fanaeian M, Albarouki S, Castelnovo LF, Peterson J, Smaglo BG, Wolff RA, Pant S, Willis J, Huey R, Overman M, Tzeng CW, Kim MP, Ikoma N, Maxwell JE, Katz MHG, Wang H, Maitra A, Koay E, Ludmir EB, Chen A, Lopez C, Ying H, Shen JP, Zhao D. KRAS mutation detection by liquid biopsy for pancreatic ductal adenocarcinoma. J Hematol Oncol 18: 44, 2025.
2. Javed, A, Hidalgo Salinas, C, Wolfgang, CL, Besselink, MG, Ahmad, SA, Ahuja, N, Andel, PC, Asbun, HJ, Bauer, TW, Boggi, U, Bonsing, BA, Büchler, M, Butturini, G, Busch, OR, Cobos, SE, Daamen, LA, Dameseviciute, R, Datta, J, Dervenis, C, Diener, MK, Dixon, E, Donahue, TR, Edil, BH, Ejaz, A, Falconi, M, Lavista Ferres, JM, Ferrone, CR, Fong, ZV, Fusai, G, Garnier, J, Koerkamp, BG, Hansen, CP, Habib, JR, Hashimoto, D, He, J, Hingh, IH, Inoue, Y, Islam, S, Jang, JY, Jiang, K, Katz, MH, Kooby, DA, Lancaster, WP, Maker, AV, Marchegiani, G, Marchetti, A, Matsumoto, I, McGinty, PA, Molenaar, IQ, Nagakawa, Y. Launch of the PANC-PALS Consortium. The Lancet Gastroenterology and Hepatology 9: 1084-1085, 2024.
3. Snyder RA, Katz MHG. NORPACT-1: implications for future trials. Lancet Gastroenterol Hepatol 9: 408, 2024.
4. Katz MHG, Herman JM, O'Reilly EM. Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial-Reply. JAMA Oncol 9: 277-278, 2023.
5. Perri G, Katz MHG. Response to the Comment on "Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma". Ann Surg 274: e718-e719, 2021.
6. Perri G, Katz MHG. Neoadjuvant Chemotherapy in Pancreatic Cancer-Reply. JAMA Surg 156: 398, 2021.
7. Brower ST, Katz MH, Pisters P, Merchant N, Weber S, Posner M. E-SORs for Pancreatic Resection. J Am Coll Surg 211: 308-15, 2011.